{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:51:10Z","timestamp":1784166670500,"version":"3.55.0"},"reference-count":259,"publisher":"Sociedade Brasileira de Cardiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,27]]},"DOI":"10.36660\/abc.20200266","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T16:08:04Z","timestamp":1632845284000},"source":"Crossref","is-referenced-by-count":10,"title":["Posicionamento Brasileiro sobre o Uso da Multimodalidade de Imagens na Cardio-Oncologia \u2013 2021"],"prefix":"10.36660","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-8783","authenticated-orcid":false,"given":"Marcelo Dantas Tavares de","family":"Melo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Goulart","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ver\u00f4nica C\u00e2mara","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4505-3344","authenticated-orcid":false,"given":"Carlos Eduardo","family":"Rochitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ria de Melo","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Hassan","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Cristina Soares","family":"Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6684-5952","authenticated-orcid":false,"given":"Claudia Cosentino","family":"Gallafrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Goldwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0477-480X","authenticated-orcid":false,"given":"Eliza de Almeida","family":"Gripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4154-3197","authenticated-orcid":false,"given":"Rafael Bonafim","family":"Piveta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9983-6438","authenticated-orcid":false,"given":"Tonnison Oliveira","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais Harada Campos Espirito","family":"Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9748-1784","authenticated-orcid":false,"given":"Waldinai Pereira","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7152-1810","authenticated-orcid":false,"given":"Vera Maria Cury","family":"Salemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanderson A.","family":"Cauduro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0711-7995","authenticated-orcid":false,"given":"Silvio Henrique","family":"Barberato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helo\u00edsa M. Christovam","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luiz Barros","family":"Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4207-4484","authenticated-orcid":false,"given":"Heron Rhydan Saad","family":"Rached","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3314-9712","authenticated-orcid":false,"given":"Marcelo Haertel","family":"Miglioranza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lio Carvalho","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-4002","authenticated-orcid":false,"given":"B\u00e1rbara Athayde Linhares Martins","family":"Vrandecic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia Beatriz Bittencourt Viana","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7131-6614","authenticated-orcid":false,"given":"C\u00e9sar Higa","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Mello Erthal","family":"Cerbino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1418-9361","authenticated-orcid":false,"given":"Isabela Bispo Santos da Silva","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4428-5186","authenticated-orcid":false,"suffix":"Filho","given":"Otavio Rizzi","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano Camargo de Castro","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7234-4046","authenticated-orcid":false,"given":"Ursula Maria Moreira Costa","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6726-5324","authenticated-orcid":false,"given":"Juliano Lara","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7302-7448","authenticated-orcid":false,"given":"Marly","family":"Uellendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7079-2600","authenticated-orcid":false,"given":"Eveline Barros","family":"Calado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6728-3565","authenticated-orcid":false,"given":"Tiago","family":"Senra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Leal","family":"Assun\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Maria Vilas","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane Nunes","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6418-1424","authenticated-orcid":false,"given":"Karen Saori Shiraishi","family":"Sawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcio Miranda","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fernanda Silva","family":"Jardim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Junqueira Moll","family":"Bernardes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza Cristina","family":"Di\u00f3genes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas de Oliveira","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1466-9413","authenticated-orcid":false,"given":"Claudio Tinoco","family":"Mesquita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Willain","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Neto","given":"Elry Medeiros Vieira","family":"Segundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia","family":"Rigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeska Leite Siqueira","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Jos\u00e9","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6485-4900","authenticated-orcid":false,"given":"Gabriel Blacher","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Cestari","family":"Quagliato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Luiza de","family":"Alcantara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Aldo Ribeiro","family":"Teodoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina Lopes","family":"Albricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanilda Souto","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomon Israel do","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen L\u00facia Lascasas","family":"Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Vin\u00edcius Lins","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Nascimento dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando Lu\u00eds","family":"Cantisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6186-1531","authenticated-orcid":false,"given":"Ana Cl\u00e1udia Gomes Pereira","family":"Petisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Eduardo Martins","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando Carlos Gl\u00f3ria","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4884-0223","authenticated-orcid":false,"given":"Salvador","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5645-2055","authenticated-orcid":false,"given":"Ludhmilla Abrah\u00e3o","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1033-3672","authenticated-orcid":false,"suffix":"Filho","given":"Roberto","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1253-1514","authenticated-orcid":false,"given":"Marcelo Ant\u00f4nio Cartaxo Queiroga","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Luiz Campos","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1777-477X","authenticated-orcid":false,"given":"Andr\u00e9 Luiz Cerqueira","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22636","reference":[{"issue":"1","key":"key20210928102019_B1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.32635\/2176-9745.RBC.2018v64n1.115","article-title":"Estimate 2018: Cancer Incidence in Brazil","volume":"64","author":"Santos","year":"2018","unstructured":"1. Santos MO. Estimate 2018: Cancer Incidence in Brazil. Revista Brasileira de Cancerologia. 2018;64(1):119-20.","journal-title":"Revista Brasileira de Cancerologia"},{"issue":"23","key":"key20210928102019_B2","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMra1204479","article-title":"Two hundred years of cancer research","volume":"366","author":"DeVita","year":"2012","unstructured":"2. DeVita VT, Jr., Rosenberg SA. Two hundred years of cancer research. N Engl J Med. 2012;366(23):2207-14.","journal-title":"N Engl J Med"},{"issue":"1","key":"key20210928102019_B3","first-page":"39","article-title":"Analysis of the Economic Impact of Cardiovascular Diseases in the Last Five Years in Brazil","volume":"109","author":"Siqueira","year":"2017","unstructured":"3. Siqueira ASE, Siqueira-Filho AG, Land MGP. Analysis of the Economic Impact of Cardiovascular Diseases in the Last Five Years in Brazil. Arq Bras Cardiol. 2017;109(1):39-46.","journal-title":"Arq Bras Cardiol"},{"issue":"36","key":"key20210928102019_B4","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","unstructured":"4. Zamorano JL, Lancellotti P, Rodriguez Munoz D, Aboyans V, Asteggiano R, Galderisi M, et al.2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(36):2768-801.","journal-title":"Eur Heart J"},{"key":"key20210928102019_B5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/EDBK_100015","article-title":"Predicting and Preventing Anthracycline-Related Cardiotoxicity","volume":"38","author":"Armenian","year":"2018","unstructured":"5. Armenian S, Bhatia S. Predicting and Preventing Anthracycline-Related Cardiotoxicity. Am Soc Clin Oncol Educ Book. 2018;38:3-12.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"8","key":"key20210928102019_B6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline","volume":"35","author":"Armenian","year":"2017","unstructured":"6. Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al.Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35(8):893-911.","journal-title":"J Clin Oncol"},{"issue":"2 Suppl 1","key":"key20210928102019_B7","first-page":"1","article-title":"I Brazilian Guideline for Cardio-Oncology from Sociedade Brasileira de Cardiologia","volume":"96","author":"Grupo de Estudos em Insuficiencia Cardiaca da Sociedade Brasileira de C, Sociedade Brasileira de Oncologia C, Instituto do Coracao - Faculdade de Medicina da Universidade de Sao P, Instituto do Cancer do Estado de Sao Paulo - Faculdade de Medicina da Universidade de Sao P","year":"2011","unstructured":"7. Grupo de Estudos em Insuficiencia Cardiaca da Sociedade Brasileira de C, Sociedade Brasileira de Oncologia C, Instituto do Coracao - Faculdade de Medicina da Universidade de Sao P, Instituto do Cancer do Estado de Sao Paulo - Faculdade de Medicina da Universidade de Sao P, Kalil Filho R, Hajjar LA, et al.[I Brazilian Guideline for Cardio-Oncology from Sociedade Brasileira de Cardiologia]. Arq Bras Cardiol. 2011;96(2 Suppl 1):1-52.","journal-title":"Arq Bras Cardiol"},{"issue":"7","key":"key20210928102019_B8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cjca.2016.02.078","article-title":"Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy","volume":"32","author":"Virani","year":"2016","unstructured":"8. Virani SA, Dent S, Brezden-Masley C, Clarke B, Davis MK, Jassal DS, et al.Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy. Can J Cardiol. 2016;32(7):831-41.","journal-title":"Can J Cardiol"},{"issue":"3","key":"key20210928102019_B9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/01.CIR.102.3.272","article-title":"Trastuzumab in the treatment of metastatic breast cancer: anticancer therapy versus cardiotoxicity","volume":"102","author":"Feldman","year":"2000","unstructured":"9. Feldman AM, Lorell BH, Reis SE. Trastuzumab in the treatment of metastatic breast cancer: anticancer therapy versus cardiotoxicity. Circulation. 2000;102(3):272-4.","journal-title":"Circulation"},{"issue":"13","key":"key20210928102019_B10","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1200\/JCO.2005.05.827","article-title":"Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity","volume":"23","author":"Ewer","year":"2005","unstructured":"10. Ewer MS, Lippman SM. Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. J Clin Oncol. 2005;23(13):2900-2.","journal-title":"J Clin Oncol"},{"issue":"22","key":"key20210928102019_B11","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","unstructured":"11. Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, et al.Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131(22):1981-8.","journal-title":"Circulation"},{"issue":"16","key":"key20210928102019_B12","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jama.2018.13995","article-title":"Immune Checkpoint Inhibitor Toxicity in 2018","volume":"320","author":"Johnson","year":"2018","unstructured":"12. Johnson DB, Chandra S, Sosman JA. Immune Checkpoint Inhibitor Toxicity in 2018. JAMA. 2018;320(16):1702-3.","journal-title":"JAMA"},{"issue":"1","key":"key20210928102019_B13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy","volume":"61","author":"Thavendiranathan","year":"2013","unstructured":"13. Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popovic ZB, Marwick TH. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol. 2013;61(1):77-84.","journal-title":"J Am Coll Cardiol"},{"key":"key20210928102019_B14","doi-asserted-by":"crossref","DOI":"10.36660\/abc.20201006","article-title":"Diretriz Brasileira de Cardio-oncologia \u2013 2020","author":"Hajjar","year":"2020","unstructured":"14. Hajjar LA, Costa IBSS, Lopes MACQ, Hoff PMG, Diz MDPE, Fonseca SMR, et al. Diretriz Brasileira de Cardio-oncologia \u2013 2020. Arq Bras Cardiol. 2020; [online]. DOI: https:\/\/doi.org\/10.36660\/abc.20201006","journal-title":"Arq Bras Cardiol"},{"issue":"8","key":"key20210928102019_B15","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jcmg.2018.06.003","article-title":"Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient","volume":"11","author":"Plana","year":"2018","unstructured":"15. Plana JC, Thavendiranathan P, Bucciarelli-Ducci C, Lancellotti P. Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient. JACC Cardiovasc Imaging. 2018;11(8):1173-86.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"key20210928102019_B16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.euje.2005.04.009","article-title":"Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study","volume":"7","author":"Tassan-Mangina","year":"2006","unstructured":"16. Tassan-Mangina S, Codorean D, Metivier M, Costa B, Himberlin C, Jouannaud C, et al.Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study. Eur J Echocardiogr. 2006;7(2):141-6.","journal-title":"Eur J Echocardiogr"},{"issue":"5","key":"key20210928102019_B17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10554-007-9286-9","article-title":"Strain and strain rate deformation parameters: from tissue Doppler to 2D speckle tracking","volume":"24","author":"Pavlopoulos","year":"2008","unstructured":"17. Pavlopoulos H, Nihoyannopoulos P. Strain and strain rate deformation parameters: from tissue Doppler to 2D speckle tracking. Int J Cardiovasc Imaging. 2008;24(5):479-91.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"12","key":"key20210928102019_B18","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.echo.2008.10.008","article-title":"Identification of anthracycline cardiotoxicity: left ventricular ejection fraction is not enough","volume":"21","author":"Eidem","year":"2008","unstructured":"18. Eidem BW. Identification of anthracycline cardiotoxicity: left ventricular ejection fraction is not enough. J Am Soc Echocardiogr. 2008;21(12):1290-2.","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"key20210928102019_B19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/CIRCRESAHA.109.210724","article-title":"Introduction to cardiotoxicity review series","volume":"106","author":"Force","year":"2010","unstructured":"19. Force T. Introduction to cardiotoxicity review series. Circ Res. 2010;106(1):19-20.","journal-title":"Circ Res"},{"issue":"12","key":"key20210928102019_B20","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1634\/theoncologist.2008-0151","article-title":"Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers","volume":"13","author":"Mantovani","year":"2008","unstructured":"20. Mantovani G, Madeddu C, Cadeddu C, Dessi M, Piras A, Massa E, et al.Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers. Oncologist. 2008;13(12):1296-305.","journal-title":"Oncologist"},{"issue":"25 Pt A","key":"key20210928102019_B21","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","article-title":"Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review","volume":"63","author":"Thavendiranathan","year":"2014","unstructured":"21. Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63(25 Pt A):2751-68.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"key20210928102019_B22","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.amjcard.2006.10.063","article-title":"Acute cardiac functional and morphological changes after Anthracycline infusions in children","volume":"99","author":"Ganame","year":"2007","unstructured":"22. Ganame J, Claus P, Eyskens B, Uyttebroeck A, Renard M, D\u2019Hooge J, et al.Acute cardiac functional and morphological changes after Anthracycline infusions in children. Am J Cardiol. 2007;99(7):974-7.","journal-title":"Am J Cardiol"},{"issue":"12","key":"key20210928102019_B23","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.echo.2007.04.007","article-title":"Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients","volume":"20","author":"Ganame","year":"2007","unstructured":"23. Ganame J, Claus P, Uyttebroeck A, Renard M, D\u2019Hooge J, Bijnens B, et al.Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients. J Am Soc Echocardiogr. 2007;20(12):1351-8.","journal-title":"J Am Soc Echocardiogr"},{"issue":"9","key":"key20210928102019_B24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.amjcard.2011.01.006","article-title":"Early detection and prediction of cardiotoxicity in chemotherapy-treated patients","volume":"107","author":"Sawaya","year":"2011","unstructured":"24. Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V, et al.Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol. 2011;107(9):1375-80.","journal-title":"Am J Cardiol"},{"issue":"5","key":"key20210928102019_B25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.echo.2015.02.001","article-title":"Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab","volume":"28","author":"Tan","year":"2015","unstructured":"25. Tan TC, Bouras S, Sawaya H, Sebag IA, Cohen V, Picard MH, et al.Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab. J Am Soc Echocardiogr. 2015;28(5):509-14.","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"key20210928102019_B26","first-page":"274","article-title":"Subclinical ventricular dysfunction detected by speckle tracking two years after use of anthracycline","volume":"104","author":"Almeida","year":"2015","unstructured":"26. Almeida ALC, Silva VA, de Souza Filho AT, Rios VG, Lopes JR, de Afonseca SO, et al.Subclinical ventricular dysfunction detected by speckle tracking two years after use of anthracycline. Arq Bras Cardiol. 2015;104(4):274-83.","journal-title":"Arq Bras Cardiol"},{"issue":"11","key":"key20210928102019_B27","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jcmg.2018.04.014","article-title":"Early Changes in Myocardial Mechanics Detected by 3-Dimensional Speckle Tracking Echocardiography in Patients Treated With Low Doses of Anthracyclines","volume":"11","author":"Piveta","year":"2018","unstructured":"27. Piveta RB, Rodrigues ACT, Vieira MLC, Fischer CH, Afonso TR, Daminello E, et al.Early Changes in Myocardial Mechanics Detected by 3-Dimensional Speckle Tracking Echocardiography in Patients Treated With Low Doses of Anthracyclines. JACC Cardiovasc Imaging. 2018;11(11):1729-31.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"key20210928102019_B28","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","unstructured":"28. Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al.Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15(10):1063-93.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"key20210928102019_B29","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jcmg.2018.03.025","article-title":"Contemporary Role of Echocardiography for Clinical Decision Making in Patients During and After Cancer Therapy","volume":"11","author":"Liu","year":"2018","unstructured":"29. Liu J, Banchs J, Mousavi N, Plana JC, Scherrer-Crosbie M, Thavendiranathan P, et al.Contemporary Role of Echocardiography for Clinical Decision Making in Patients During and After Cancer Therapy. JACC Cardiovasc Imaging. 2018;11(8):1122-31.","journal-title":"JACC Cardiovasc Imaging"},{"key":"key20210928102019_B30","article-title":"Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy","author":"Thavendiranathan","year":"2020","unstructured":"30. Thavendiranathan P, Negishi T, Somerset E, Negishi K, Penicka M, Lemieux J, Aakhus S, Miyazaki S, Shirazi M, Galderisi M, Marwick TH, on behalf of the SUCCOUR investigators, Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy, Journal of the American College of Cardiology (2020), doi: https:\/\/doi.org\/10.1016\/j.jacc.2020.11.020.","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"key20210928102019_B31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ehjci\/jet159","article-title":"Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection","volume":"15","author":"Negishi","year":"2014","unstructured":"31. Negishi K, Negishi T, Haluska BA, Hare JL, Plana JC, Marwick TH. Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection. Eur Heart J Cardiovasc Imaging. 2014;15(3):324-31.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"key20210928102019_B32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jacc.2012.10.006","article-title":"Is echocardiography reliable for monitoring the adverse cardiac effects of chemotherapy?","volume":"61","author":"Mor-Avi","year":"2013","unstructured":"32. Mor-Avi V, Lang RM. Is echocardiography reliable for monitoring the adverse cardiac effects of chemotherapy? J Am Coll Cardiol. 2013;61(1):85-7.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"key20210928102019_B33","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/eurheartj\/ehp187","article-title":"Quantification of left ventricular volumes using three-dimensional echocardiographic speckle tracking: comparison with MRI","volume":"30","author":"Nesser","year":"2009","unstructured":"33. Nesser HJ, Mor-Avi V, Gorissen W, Weinert L, Steringer-Mascherbauer R, Niel J, et al.Quantification of left ventricular volumes using three-dimensional echocardiographic speckle tracking: comparison with MRI. Eur Heart J. 2009;30(13):1565-73.","journal-title":"Eur Heart J"},{"issue":"23","key":"key20210928102019_B34","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.2011.40.3584","article-title":"Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging","volume":"30","author":"Armstrong","year":"2012","unstructured":"34. Armstrong GT, Plana JC, Zhang N, Srivastava D, Green DM, Ness KK, et al.Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging. J Clin Oncol. 2012;30(23):2876-84.","journal-title":"J Clin Oncol"},{"issue":"4","key":"key20210928102019_B35","first-page":"359","article-title":"Validation of a novel automated border-detection algorithm for rapid and accurate quantitation of left ventricular volumes based on three-dimensional echocardiography","volume":"11","author":"Muraru","year":"2010","unstructured":"35. Muraru D, Badano LP, Piccoli G, Gianfagna P, Del Mestre L, Ermacora D, et al.Validation of a novel automated border-detection algorithm for rapid and accurate quantitation of left ventricular volumes based on three-dimensional echocardiography. Eur J Echocardiogr. 2010;11(4):359-68.","journal-title":"Eur J Echocardiogr"},{"issue":"8","key":"key20210928102019_B36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.echo.2014.05.011","article-title":"Guidelines for the cardiac sonographer in the performance of contrast echocardiography: a focused update from the American Society of Echocardiography","volume":"27","author":"Porter","year":"2014","unstructured":"36. Porter TR, Abdelmoneim S, Belcik JT, McCulloch ML, Mulvagh SL, Olson JJ, et al.Guidelines for the cardiac sonographer in the performance of contrast echocardiography: a focused update from the American Society of Echocardiography. J Am Soc Echocardiogr. 2014;27(8):797-810.","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"key20210928102019_B37","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000432","article-title":"Cardiorespiratory fitness in breast cancer patients: a call for normative values","volume":"3","author":"Peel","year":"2014","unstructured":"37. Peel AB, Thomas SM, Dittus K, Jones LW, Lakoski SG. Cardiorespiratory fitness in breast cancer patients: a call for normative values. J Am Heart Assoc. 2014;3(1):e000432.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"key20210928102019_B38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10549-013-2818-1","article-title":"Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy","volume":"143","author":"Khouri","year":"2014","unstructured":"38. Khouri MG, Hornsby WE, Risum N, Velazquez EJ, Thomas S, Lane A, et al.Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy. Breast Cancer Res Treat. 2014;143(3):531-9.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"key20210928102019_B39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijcard.2005.07.029","article-title":"Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity","volume":"111","author":"Civelli","year":"2006","unstructured":"39. Civelli M, Cardinale D, Martinoni A, Lamantia G, Colombo N, Colombo A, et al.Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity. Int J Cardiol. 2006;111(1):120-6.","journal-title":"Int J Cardiol"},{"key":"key20210928102019_B40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/IJWH.S68745","article-title":"The utility of cardiac stress testing for detection of cardiovascular disease in breast cancer survivors: a systematic review","volume":"7","author":"Kirkham","year":"2015","unstructured":"40. Kirkham AA, Virani SA, Campbell KL. The utility of cardiac stress testing for detection of cardiovascular disease in breast cancer survivors: a systematic review. Int J Womens Health. 2015;7:127-40.","journal-title":"Int J Womens Health"},{"issue":"9","key":"key20210928102019_B41","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0002-9149(01)01476-X","article-title":"Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children","volume":"87","author":"Eidem","year":"2001","unstructured":"41. Eidem BW, Sapp BG, Suarez CR, Cetta F. Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children. Am J Cardiol. 2001;87(9):1120-2, A9.","journal-title":"Am J Cardiol"},{"issue":"11","key":"key20210928102019_B42","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0002-9149(00)01222-4","article-title":"Sequential evaluation of left ventricular myocardial performance in children after anthracycline therapy","volume":"86","author":"Ishii","year":"2000","unstructured":"42. Ishii M, Tsutsumi T, Himeno W, Eto G, Furui J, Hashino K, et al.Sequential evaluation of left ventricular myocardial performance in children after anthracycline therapy. Am J Cardiol. 2000;86(11):1279-81, A9.","journal-title":"Am J Cardiol"},{"issue":"10","key":"key20210928102019_B43","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/hrt.2003.027516","article-title":"Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function","volume":"90","author":"Dorup","year":"2004","unstructured":"43. Dorup I, Levitt G, Sullivan I, Sorensen K. Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function. Heart. 2004;90(10):1214-6.","journal-title":"Heart"},{"issue":"5","key":"key20210928102019_B44","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.echo.2013.02.008","article-title":"Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity","volume":"26","author":"Negishi","year":"2013","unstructured":"44. Negishi K, Negishi T, Hare JL, Haluska BA, Plana JC, Marwick TH. Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J Am Soc Echocardiogr. 2013;26(5):493-8.","journal-title":"J Am Soc Echocardiogr"},{"issue":"7","key":"key20210928102019_B45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/clc.22672","article-title":"The influence of chemotherapy on the right ventricle: did we forget something?","volume":"40","author":"Tadic","year":"2017","unstructured":"45. Tadic M, Cuspidi C, Hering D, Venneri L, Danylenko O. The influence of chemotherapy on the right ventricle: did we forget something? Clin Cardiol. 2017;40(7):437-43.","journal-title":"Clin Cardiol"},{"issue":"3","key":"key20210928102019_B46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/ERP-16-0020","article-title":"Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy","volume":"3","author":"Boczar","year":"2016","unstructured":"46. Boczar KE, Aseyev O, Sulpher J, Johnson C, Burwash IG, Turek M, et al.Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy. Echo Res Pract. 2016;3(3):79-84.","journal-title":"Echo Res Pract"},{"key":"key20210928102019_B47","doi-asserted-by":"crossref","first-page":"609194","DOI":"10.1155\/2015\/609194","article-title":"Right Ventricular Dysfunction in Patients Experiencing Cardiotoxicity during Breast Cancer Therapy","volume":"2015","author":"Calleja","year":"2015","unstructured":"47. Calleja A, Poulin F, Khorolsky C, Shariat M, Bedard PL, Amir E, et al.Right Ventricular Dysfunction in Patients Experiencing Cardiotoxicity during Breast Cancer Therapy. J Oncol. 2015;2015:609194.","journal-title":"J Oncol"},{"issue":"10","key":"key20210928102019_B48","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0002-9149(97)89179-5","article-title":"Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions","volume":"77","author":"van Royen","year":"1996","unstructured":"48. van Royen N, Jaffe CC, Krumholz HM, Johnson KM, Lynch PJ, Natale D, et al.Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol. 1996;77(10):843-50.","journal-title":"Am J Cardiol"},{"issue":"11","key":"key20210928102019_B49","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/sj.bjc.6600346","article-title":"Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients","volume":"86","author":"Nousiainen","year":"2002","unstructured":"49. Nousiainen T, Jantunen E, Vanninen E, Hartikainen J. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients. Br J Cancer. 2002;86(11):1697-700.","journal-title":"Br J Cancer"},{"issue":"2","key":"key20210928102019_B50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10741-017-9594-7","article-title":"SPECT and PET in ischemic heart failure","volume":"22","author":"Angelidis","year":"2017","unstructured":"50. Angelidis G, Giamouzis G, Karagiannis G, Butler J, Tsougos I, Valotassiou V, et al.SPECT and PET in ischemic heart failure. Heart Fail Rev. 2017;22(2):243-61.","journal-title":"Heart Fail Rev"},{"issue":"3","key":"key20210928102019_B51","first-page":"228","article-title":"Cardiac sympathetic hyperactivity after chemotherapy: early sign of cardiotoxicity?","volume":"105","author":"Guimaraes","year":"2015","unstructured":"51. Guimaraes SL, Brandao SC, Andrade LR, Maia RJ, Markman Filho B. Cardiac sympathetic hyperactivity after chemotherapy: early sign of cardiotoxicity? Arq Bras Cardiol. 2015;105(3):228-34.","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"key20210928102019_B52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcmg.2009.07.014","article-title":"Cardiac sympathetic imaging with mIBG in heart failure","volume":"3","author":"Carrio","year":"2010","unstructured":"52. Carrio I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging. 2010;3(1):92-100.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"key20210928102019_B53","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4329\/wjr.v4.i5.220","article-title":"Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity?","volume":"4","author":"Borde","year":"2012","unstructured":"53. Borde C, Kand P, Basu S. Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity? World J Radiol. 2012;4(5):220-3.","journal-title":"World J Radiol"},{"issue":"3","key":"key20210928102019_B54","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ijrobp.2006.06.007","article-title":"The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage","volume":"66","author":"Jingu","year":"2006","unstructured":"54. Jingu K, Kaneta T, Nemoto K, Ichinose A, Oikawa M, Takai Y, et al.The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage. Int J Radiat Oncol Biol Phys. 2006;66(3):845-51.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"key20210928102019_B55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/thy.2010.0270","article-title":"Fatal heart failure after a 26-month combination of tyrosine kinase inhibitors in a papillary thyroid cancer","volume":"21","author":"Toubert","year":"2011","unstructured":"55. Toubert ME, Vercellino L, Faugeron I, Lussato D, Hindie E, Bousquet G. Fatal heart failure after a 26-month combination of tyrosine kinase inhibitors in a papillary thyroid cancer. Thyroid. 2011;21(4):451-4.","journal-title":"Thyroid"},{"issue":"5","key":"key20210928102019_B56","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/cvr\/cvz026","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors","volume":"115","author":"Hu","year":"2019","unstructured":"56. Hu JR, Florido R, Lipson EJ, Naidoo J, Ardehali R, Tocchetti CG, et al.Cardiovascular toxicities associated with immune checkpoint inhibitors. Cardiovasc Res. 2019;115(5):854-68.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"key20210928102019_B57","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep.28382","article-title":"Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis","volume":"63","author":"Locatelli","year":"2016","unstructured":"57. Locatelli L, Cadamuro M, Spirli C, Fiorotto R, Lecchi S, Morell CM, et al.Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis. Hepatology. 2016;63(3):965-82.","journal-title":"Hepatology"},{"issue":"1","key":"key20210928102019_B58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.radonc.2013.07.021","article-title":"Cardiac (1)(8)F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy","volume":"109","author":"Evans","year":"2013","unstructured":"58. Evans JD, Gomez DR, Chang JY, Gladish GW, Erasmus JJ, Rebueno N, et al.Cardiac (1)(8)F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy. Radiother Oncol. 2013;109(1):82-8.","journal-title":"Radiother Oncol"},{"issue":"6","key":"key20210928102019_B59","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/CIRCIMAGING.113.000899","article-title":"Cardiac MRI in the assessment of cardiac injury and toxicity from cancer chemotherapy: a systematic review","volume":"6","author":"Thavendiranathan","year":"2013","unstructured":"59. Thavendiranathan P, Wintersperger BJ, Flamm SD, Marwick TH. Cardiac MRI in the assessment of cardiac injury and toxicity from cancer chemotherapy: a systematic review. Circ Cardiovasc Imaging. 2013;6(6):1080-91.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"8","key":"key20210928102019_B60","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jcmg.2018.06.004","article-title":"Cardiovascular Magnetic Resonance in the Oncology Patient","volume":"11","author":"Jordan","year":"2018","unstructured":"60. Jordan JH, Todd RM, Vasu S, Hundley WG. Cardiovascular Magnetic Resonance in the Oncology Patient. JACC Cardiovasc Imaging. 2018;11(8):1150-72.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"key20210928102019_B61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12968-017-0373-3","article-title":"Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy","volume":"19","author":"Jolly","year":"2017","unstructured":"61. Jolly MP, Jordan JH, Melendez GC, McNeal GR, D\u2019Agostino RB, Jr., Hundley WG. Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy. J Cardiovasc Magn Reson. 2017;19(1):59.","journal-title":"J Cardiovasc Magn Reson"},{"key":"key20210928102019_B62","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijcard.2018.03.041","article-title":"Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy","volume":"261","author":"Ong","year":"2018","unstructured":"62. Ong G, Brezden-Masley C, Dhir V, Deva DP, Chan KKW, Chow CM, et al.Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy. Int J Cardiol. 2018;261:228-33.","journal-title":"Int J Cardiol"},{"issue":"8","key":"key20210928102019_B63","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","article-title":"Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease","volume":"6","author":"Drafts","year":"2013","unstructured":"63. Drafts BC, Twomley KM, D\u2019Agostino R, Jr., Lawrence J, Avis N, Ellis LR, et al.Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. JACC Cardiovasc Imaging. 2013;6(8):877-85.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"key20210928102019_B64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1532-429X-15-35","article-title":"Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing","volume":"15","author":"Schulz-Menger","year":"2013","unstructured":"64. Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al.Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013;15(1):35.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"6 Suppl 3","key":"key20210928102019_B65","first-page":"1","article-title":"II Guidelines on Cardiovascular Magnetic Resonance and Computed Tomography of the Brazilian Society of Cardiology and the Brazilian College of Radiology","volume":"103","author":"Sara","year":"2014","unstructured":"65. Sara L, Szarf G, Tachibana A, Shiozaki AA, Villa AV, de Oliveira AC, et al.[II Guidelines on Cardiovascular Magnetic Resonance and Computed Tomography of the Brazilian Society of Cardiology and the Brazilian College of Radiology]. Arq Bras Cardiol. 2014;103(6 Suppl 3):1-86.","journal-title":"Arq Bras Cardiol"},{"issue":"9","key":"key20210928102019_B66","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1055\/s-2004-813416","article-title":"Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer","volume":"176","author":"Oberholzer","year":"2004","unstructured":"66. Oberholzer K, Kunz RP, Dittrich M, Thelen M. [Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer]. Rofo. 2004;176(9):1245-50.","journal-title":"Rofo"},{"issue":"12","key":"key20210928102019_B67","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003584","article-title":"Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging","volume":"9","author":"Farhad","year":"2016","unstructured":"67. Farhad H, Staziaki PV, Addison D, Coelho-Filho OR, Shah RV, Mitchell RN, et al.Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging. Circ Cardiovasc Imaging. 2016;9(12)e003584.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"15","key":"key20210928102019_B68","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/eurheartj\/ehi258","article-title":"Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies","volume":"26","author":"Mahrholdt","year":"2005","unstructured":"68. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26(15):1461-74.","journal-title":"Eur Heart J"},{"issue":"5","key":"key20210928102019_B69","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/pbc.25381","article-title":"Prospective cardiac MRI for the analysis of biventricular function in children undergoing cancer treatments","volume":"62","author":"de Ville de Goyet","year":"2015","unstructured":"69. de Ville de Goyet M, Brichard B, Robert A, Renard L, Veyckemans F, Vanhoutte L, et al.Prospective cardiac MRI for the analysis of biventricular function in children undergoing cancer treatments. Pediatr Blood Cancer. 2015;62(5):867-74.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"key20210928102019_B70","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1532-429X-10-5","article-title":"Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy","volume":"10","author":"Fallah-Rad","year":"2008","unstructured":"70. Fallah-Rad N, Lytwyn M, Fang T, Kirkpatrick I, Jassal DS. Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy. J Cardiovasc Magn Reson. 2008;10(1):5.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"8","key":"key20210928102019_B71","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1634\/theoncologist.2018-0157","article-title":"Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action","volume":"23","author":"Neilan","year":"2018","unstructured":"71. Neilan TG, Rothenberg ML, Amiri-Kordestani L, Sullivan RJ, Steingart RM, Gregory W, et al.Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action. Oncologist. 2018;23(8):874-8.","journal-title":"Oncologist"},{"issue":"16","key":"key20210928102019_B72","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in Patients Treated With Immune Checkpoint Inhibitors","volume":"71","author":"Mahmood","year":"2018","unstructured":"72. Mahmood SS, Fradley MG, Cohen JV, Nohria A, Reynolds KL, Heinzerling LM, et al.Myocarditis in Patients Treated With Immune Checkpoint Inhibitors. J Am Coll Cardiol. 2018;71(16):1755-64.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"key20210928102019_B73","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jcmg.2016.06.006","article-title":"Progressive 3-Month Increase in LV Myocardial ECV After Anthracycline-Based Chemotherapy","volume":"10","author":"Melendez","year":"2017","unstructured":"73. Melendez GC, Jordan JH, D\u2019Agostino RB, Jr., Vasu S, Hamilton CA, Hundley WG. Progressive 3-Month Increase in LV Myocardial ECV After Anthracycline-Based Chemotherapy. JACC Cardiovasc Imaging. 2017;10(6):708-9.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"key20210928102019_B74","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jcmg.2018.05.012","article-title":"Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease","volume":"11","author":"Ferreira de Souza","year":"2018","unstructured":"74. Ferreira de Souza T, Quinaglia ACST, Osorio Costa F, Shah R, Neilan TG, Velloso L, et al.Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease. JACC Cardiovasc Imaging. 2018;11(8):1045-55.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"key20210928102019_B75","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcmg.2008.09.014","article-title":"Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis","volume":"2","author":"Zagrosek","year":"2009","unstructured":"75. Zagrosek A, Abdel-Aty H, Boye P, Wassmuth R, Messroghli D, Utz W, et al.Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging. 2009;2(2):131-8.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"19","key":"key20210928102019_B76","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/01.CIR.100.19.1992","article-title":"Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function","volume":"100","author":"Kim","year":"1999","unstructured":"76. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al.Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100(19):1992-2002.","journal-title":"Circulation"},{"issue":"10","key":"key20210928102019_B77","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","article-title":"Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy","volume":"48","author":"Assomull","year":"2006","unstructured":"77. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, et al.Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48(10):1977-85.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"key20210928102019_B78","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jacc.2013.01.019","article-title":"Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer","volume":"61","author":"Ylanen","year":"2013","unstructured":"78. Ylanen K, Poutanen T, Savikurki-Heikkila P, Rinta-Kiikka I, Eerola A, Vettenranta K. Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer. J Am Coll Cardiol. 2013;61(14):1539-47.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"key20210928102019_B79","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2010.11.063","article-title":"The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy","volume":"57","author":"Fallah-Rad","year":"2011","unstructured":"79. Fallah-Rad N, Walker JR, Wassef A, Lytwyn M, Bohonis S, Fang T, et al.The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol. 2011;57(22):2263-70.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"key20210928102019_B80","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.jacc.2011.06.071","article-title":"Late gadolinium enhancement in left ventricular dysfunction after trastuzumab","volume":"58","author":"Wassmuth","year":"2011","unstructured":"80. Wassmuth R, Schulz-Menger J. Late gadolinium enhancement in left ventricular dysfunction after trastuzumab. J Am Coll Cardiol. 2011;58(25):2697-8; author reply 9-700.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20210928102019_B81","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1743-7563.2011.01462.x","article-title":"Pilot study evaluating the role of cardiac magnetic resonance imaging in monitoring adjuvant trastuzumab therapy for breast cancer","volume":"8","author":"Lawley","year":"2012","unstructured":"81. Lawley C, Wainwright C, Segelov E, Lynch J, Beith J, McCrohon J. Pilot study evaluating the role of cardiac magnetic resonance imaging in monitoring adjuvant trastuzumab therapy for breast cancer. Asia Pac J Clin Oncol. 2012;8(1):95-100.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"8","key":"key20210928102019_B82","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004325","article-title":"Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors","volume":"9","author":"Jordan","year":"2016","unstructured":"82. Jordan JH, Vasu S, Morgan TM, D\u2019Agostino RB, Jr., Melendez GC, Hamilton CA, et al.Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors. Circ Cardiovasc Imaging. 2016;9(8).","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"key20210928102019_B83","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood-2006-10-053736","article-title":"Trousseau\u2019s syndrome: multiple definitions and multiple mechanisms","volume":"110","author":"Varki","year":"2007","unstructured":"83. Varki A. Trousseau\u2019s syndrome: multiple definitions and multiple mechanisms. Blood. 2007;110(6):1723-9.","journal-title":"Blood"},{"key":"key20210928102019_B84","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12957-015-0592-8","article-title":"Venous thromboembolism in cancer patients: an underestimated major health problem","volume":"13","author":"Khalil","year":"2015","unstructured":"84. Khalil J, Bensaid B, Elkacemi H, Afif M, Bensaid Y, Kebdani T, et al.Venous thromboembolism in cancer patients: an underestimated major health problem. World J Surg Oncol. 2015;13:204.","journal-title":"World J Surg Oncol"},{"issue":"4","key":"key20210928102019_B85","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0037-1613051","article-title":"Venous thrombosis in patients with solid tumors: determination of frequency and characteristics","volume":"87","author":"Sallah","year":"2002","unstructured":"85. Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost. 2002;87(4):575-9.","journal-title":"Thromb Haemost"},{"issue":"1","key":"key20210928102019_B86","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1160\/TH15-08-0686","article-title":"Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study","volume":"117","author":"Cohen","year":"2017","unstructured":"86. Cohen AT, Katholing A, Rietbrock S, Bamber L, Martinez C. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study. Thromb Haemost. 2017;117(1):57-65.","journal-title":"Thromb Haemost"},{"issue":"10","key":"key20210928102019_B87","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","unstructured":"87. Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood. 2013;122(10):1712-23.","journal-title":"Blood"},{"issue":"7","key":"key20210928102019_B88","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bjc.6605883","article-title":"Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006","volume":"103","author":"Cronin-Fenton","year":"2010","unstructured":"88. Cronin-Fenton DP, Sondergaard F, Pedersen LA, Fryzek JP, Cetin K, Acquavella J, et al.Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006. Br J Cancer. 2010;103(7):947-53.","journal-title":"Br J Cancer"},{"issue":"14","key":"key20210928102019_B89","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCULATIONAHA.117.030687","article-title":"Ultrasound for Lower Extremity Deep Venous Thrombosis: Multidisciplinary Recommendations From the Society of Radiologists in Ultrasound Consensus Conference","volume":"137","author":"Needleman","year":"2018","unstructured":"89. Needleman L, Cronan JJ, Lilly MP, Merli GJ, Adhikari S, Hertzberg BS, et al.Ultrasound for Lower Extremity Deep Venous Thrombosis: Multidisciplinary Recommendations From the Society of Radiologists in Ultrasound Consensus Conference. Circulation. 2018;137(14):1505-15.","journal-title":"Circulation"},{"issue":"12","key":"key20210928102019_B90","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMra011883","article-title":"Preventing complications of central venous catheterization","volume":"348","author":"McGee","year":"2003","unstructured":"90. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;348(12):1123-33.","journal-title":"N Engl J Med"},{"issue":"19","key":"key20210928102019_B91","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1200\/JCO.2003.08.008","article-title":"Venous thromboembolism associated with long-term use of central venous catheters in cancer patients","volume":"21","author":"Verso","year":"2003","unstructured":"91. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol. 2003;21(19):3665-75.","journal-title":"J Clin Oncol"},{"issue":"4","key":"key20210928102019_B92","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1055\/s-0038-1648912","article-title":"Pulmonary embolism in patients with upper extremity DVT associated to venous central lines--a prospective study","volume":"72","author":"Monreal","year":"1994","unstructured":"92. Monreal M, Raventos A, Lerma R, Ruiz J, Lafoz E, Alastrue A, et al.Pulmonary embolism in patients with upper extremity DVT associated to venous central lines--a prospective study. Thromb Haemost. 1994;72(4):548-50.","journal-title":"Thromb Haemost"},{"issue":"2","key":"key20210928102019_B93","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1538-7836.2010.04126.x","article-title":"Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies","volume":"9","author":"Saber","year":"2011","unstructured":"93. Saber W, Moua T, Williams EC, Verso M, Agnelli G, Couban S, et al.Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost. 2011;9(2):312-9.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"key20210928102019_B94","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/1097-0142(20010215)91:4<806::AID-CNCR1068>3.0.CO;2-K","article-title":"Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2","volume":"91","author":"Eastman","year":"2001","unstructured":"94. Eastman ME, Khorsand M, Maki DG, Williams EC, Kim K, Sondel PM, et al.Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2. Cancer. 2001;91(4):806-14.","journal-title":"Cancer"},{"issue":"6","key":"key20210928102019_B95","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/bjh.12474","article-title":"Catheter-related thrombosis in cancer patients","volume":"162","author":"Murray","year":"2013","unstructured":"95. Murray J, Precious E, Alikhan R. Catheter-related thrombosis in cancer patients. Br J Haematol. 2013;162(6):748-57.","journal-title":"Br J Haematol"},{"issue":"10","key":"key20210928102019_B96","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11886-018-1034-3","article-title":"Venous Thromboembolism and Cancer","volume":"20","author":"Schmaier","year":"2018","unstructured":"96. Schmaier AA, Ambesh P, Campia U. Venous Thromboembolism and Cancer. Curr Cardiol Rep. 2018;20(10):89.","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"key20210928102019_B97","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.hfc.2018.03.004","article-title":"Imaging the Right Heart-Pulmonary Circulation Unit: The Role of MRI and Computed Tomography","volume":"14","author":"Dellegrottaglie","year":"2018","unstructured":"97. Dellegrottaglie S, Ostenfeld E, Sanz J, Scatteia A, Perrone-Filardi P, Bossone E. Imaging the Right Heart-Pulmonary Circulation Unit: The Role of MRI and Computed Tomography. Heart Fail Clin. 2018;14(3):377-91.","journal-title":"Heart Fail Clin"},{"issue":"1","key":"key20210928102019_B98","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1148\/radiol.2018180603","article-title":"Diagnosis of Pulmonary Hypertension with Cardiac MRI: Derivation and Validation of Regression Models","volume":"290","author":"Johns","year":"2019","unstructured":"98. Johns CS, Kiely DG, Rajaram S, Hill C, Thomas S, Karunasaagarar K, et al.Diagnosis of Pulmonary Hypertension with Cardiac MRI: Derivation and Validation of Regression Models. Radiology. 2019;290(1):61-8.","journal-title":"Radiology"},{"issue":"10","key":"key20210928102019_B99","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.mri.2015.08.005","article-title":"A non-invasive assessment of cardiopulmonary hemodynamics with MRI in pulmonary hypertension","volume":"33","author":"Bane","year":"2015","unstructured":"99. Bane O, Shah SJ, Cuttica MJ, Collins JD, Selvaraj S, Chatterjee NR, et al.A non-invasive assessment of cardiopulmonary hemodynamics with MRI in pulmonary hypertension. Magn Reson Imaging. 2015;33(10):1224-35.","journal-title":"Magn Reson Imaging"},{"issue":"6","key":"key20210928102019_B100","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/HCO.0000000000000559","article-title":"Novel imaging techniques in pulmonary hypertension","volume":"33","author":"Johns","year":"2018","unstructured":"100. Johns CS, Kiely DG, Swift AJ. Novel imaging techniques in pulmonary hypertension. Curr Opin Cardiol. 2018;33(6):587-93.","journal-title":"Curr Opin Cardiol"},{"issue":"8","key":"key20210928102019_B101","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s10554-018-1448-4","article-title":"Advanced imaging in pulmonary hypertension: emerging techniques and applications","volume":"35","author":"Rengier","year":"2019","unstructured":"101. Rengier F, Melzig C, Derlin T, Marra AM, Vogel-Claussen J. Advanced imaging in pulmonary hypertension: emerging techniques and applications. Int J Cardiovasc Imaging. 2019;35(8):1407-20.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"3","key":"key20210928102019_B102","first-page":"257","article-title":"Risks of heart disease after radiotherapy","volume":"38","author":"Cutter","year":"2011","unstructured":"102. Cutter DJ, Darby SC, Yusuf SW. Risks of heart disease after radiotherapy. Tex Heart Inst J. 2011;38(3):257-8.","journal-title":"Tex Heart Inst J"},{"issue":"10","key":"key20210928102019_B103","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/eurheartj\/eht114","article-title":"Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease","volume":"35","author":"Groarke","year":"2014","unstructured":"103. Groarke JD, Nguyen PL, Nohria A, Ferrari R, Cheng S, Moslehi J. Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease. Eur Heart J. 2014;35(10):612-23.","journal-title":"Eur Heart J"},{"issue":"10","key":"key20210928102019_B104","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.amjcard.2013.07.031","article-title":"Cardiovascular complications of radiotherapy","volume":"112","author":"Lee","year":"2013","unstructured":"104. Lee MS, Finch W, Mahmud E. Cardiovascular complications of radiotherapy. Am J Cardiol. 2013;112(10):1688-96.","journal-title":"Am J Cardiol"},{"issue":"11","key":"key20210928102019_B105","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","unstructured":"105. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al.Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987-98.","journal-title":"N Engl J Med"},{"issue":"11","key":"key20210928102019_B106","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.amjcard.2016.08.050","article-title":"Meta-Analysis of Association Between Mediastinal Radiotherapy and Long-Term Heart Failure","volume":"118","author":"Nolan","year":"2016","unstructured":"106. Nolan MT, Russell DJ, Negishi K, Marwick TH. Meta-Analysis of Association Between Mediastinal Radiotherapy and Long-Term Heart Failure. Am J Cardiol. 2016;118(11):1685-91.","journal-title":"Am J Cardiol"},{"issue":"4","key":"key20210928102019_B107","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jacbts.2018.01.014","article-title":"Radiation-Induced Endothelial Vascular Injury: A Review of Possible Mechanisms","volume":"3","author":"Venkatesulu","year":"2018","unstructured":"107. Venkatesulu BP, Mahadevan LS, Aliru ML, Yang X, Bodd MH, Singh PK, et al.Radiation-Induced Endothelial Vascular Injury: A Review of Possible Mechanisms. JACC Basic Transl Sci. 2018;3(4):563-72.","journal-title":"JACC Basic Transl Sci"},{"issue":"4","key":"key20210928102019_B108","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/heartjnl-2015-308765","article-title":"Radiation-induced valvular heart disease","volume":"102","author":"Gujral","year":"2016","unstructured":"108. Gujral DM, Lloyd G, Bhattacharyya S. Radiation-induced valvular heart disease. Heart. 2016;102(4):269-76.","journal-title":"Heart"},{"issue":"23","key":"key20210928102019_B109","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2013.01.090","article-title":"Cardiac complications of thoracic irradiation","volume":"61","author":"Jaworski","year":"2013","unstructured":"109. Jaworski C, Mariani JA, Wheeler G, Kaye DM. Cardiac complications of thoracic irradiation. J Am Coll Cardiol. 2013;61(23):2319-28.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"key20210928102019_B110","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005633","article-title":"Long-Term Cardiovascular Risk After Radiotherapy in Women With Breast Cancer","volume":"6","author":"Cheng","year":"2017","unstructured":"110. Cheng YJ, Nie XY, Ji CC, Lin XX, Liu LJ, Chen XM, et al.Long-Term Cardiovascular Risk After Radiotherapy in Women With Breast Cancer. J Am Heart Assoc. 2017;6(5).","journal-title":"J Am Heart Assoc"},{"issue":"20","key":"key20210928102019_B111","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/heartjnl-2017-312123","article-title":"How to prevent and manage radiation-induced coronary artery disease","volume":"104","author":"Cuomo","year":"2018","unstructured":"111. Cuomo JR, Javaheri SP, Sharma GK, Kapoor D, Berman AE, Weintraub NL. How to prevent and manage radiation-induced coronary artery disease. Heart. 2018;104(20):1647-53.","journal-title":"Heart"},{"issue":"2","key":"key20210928102019_B112","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jvs.2003.08.031","article-title":"Accelerated progression of carotid stenosis in patients with previous external neck irradiation","volume":"39","author":"Cheng","year":"2004","unstructured":"112. Cheng SW, Ting AC, Ho P, Wu LL. Accelerated progression of carotid stenosis in patients with previous external neck irradiation. J Vasc Surg. 2004;39(2):409-15.","journal-title":"J Vasc Surg"},{"issue":"10","key":"key20210928102019_B113","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.7863\/jum.2003.22.10.1055","article-title":"Cerebral blood flow measurement by color velocity imaging in radiation-induced carotid stenosis","volume":"22","author":"Lam","year":"2003","unstructured":"113. Lam WW, Ho SS, Leung SF, Wong KS, Metreweli C. Cerebral blood flow measurement by color velocity imaging in radiation-induced carotid stenosis. J Ultrasound Med. 2003;22(10):1055-60.","journal-title":"J Ultrasound Med"},{"issue":"3","key":"key20210928102019_B114","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1006\/gyno.2001.6525","article-title":"Iliac atherosclerotic occlusive disease complicating radiation therapy for cervix cancer: a case series","volume":"84","author":"Moutardier","year":"2002","unstructured":"114. Moutardier V, Christophe M, Lelong B, Houvenaeghel G, Delpero JR. Iliac atherosclerotic occlusive disease complicating radiation therapy for cervix cancer: a case series. Gynecol Oncol. 2002;84(3):456-9.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"key20210928102019_B115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000363068","article-title":"Radiation-induced carotid artery stenosis: a comprehensive review of the literature","volume":"2","author":"Xu","year":"2014","unstructured":"115. Xu J, Cao Y. Radiation-induced carotid artery stenosis: a comprehensive review of the literature. Interv Neurol. 2014;2(4):183-92.","journal-title":"Interv Neurol"},{"issue":"11","key":"key20210928102019_B116","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/00005537-200011000-00007","article-title":"A prospective study of the effects of irradiation on the carotid artery","volume":"110","author":"Muzaffar","year":"2000","unstructured":"116. Muzaffar K, Collins SL, Labropoulos N, Baker WH. A prospective study of the effects of irradiation on the carotid artery. Laryngoscope. 2000;110(11):1811-4.","journal-title":"Laryngoscope"},{"issue":"3","key":"key20210928102019_B117","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.radonc.2014.10.012","article-title":"Progression of carotid intima media thickness after radiotherapy: a long-term prospective cohort study","volume":"113","author":"Wilbers","year":"2014","unstructured":"117. Wilbers J, Dorresteijn LD, Haast R, Hoebers FJ, Kaanders JH, Boogerd W, et al.Progression of carotid intima media thickness after radiotherapy: a long-term prospective cohort study. Radiother Oncol. 2014;113(3):359-63.","journal-title":"Radiother Oncol"},{"issue":"4","key":"key20210928102019_B118","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/pbc.22111","article-title":"Premature carotid artery disease in pediatric cancer survivors treated with neck irradiation","volume":"53","author":"Meeske","year":"2009","unstructured":"118. Meeske KA, Siegel SE, Gilsanz V, Bernstein L, Nelson MB, Sposto R, et al.Premature carotid artery disease in pediatric cancer survivors treated with neck irradiation. Pediatr Blood Cancer. 2009;53(4):615-21.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"key20210928102019_B119","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.semarthrit.2012.07.005","article-title":"The role of multimodality imaging in the evaluation of Takayasu arteritis","volume":"42","author":"Mavrogeni","year":"2013","unstructured":"119. Mavrogeni S, Dimitroulas T, Chatziioannou SN, Kitas G. The role of multimodality imaging in the evaluation of Takayasu arteritis. Semin Arthritis Rheum. 2013;42(4):401-12.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"key20210928102019_B120","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0741-5214(99)70042-X","article-title":"Accelerated carotid artery disease after high-dose head and neck radiotherapy: is there a role for routine carotid duplex surveillance?","volume":"30","author":"Carmody","year":"1999","unstructured":"120. Carmody BJ, Arora S, Avena R, Curry KM, Simpkins J, Cosby K, et al.Accelerated carotid artery disease after high-dose head and neck radiotherapy: is there a role for routine carotid duplex surveillance? J Vasc Surg. 1999;30(6):1045-51.","journal-title":"J Vasc Surg"},{"issue":"3","key":"key20210928102019_B121","doi-asserted-by":"crossref","first-page":"629 e1-5","DOI":"10.1016\/j.jvs.2010.09.056","article-title":"Outcomes of carotid artery stenting versus historical surgical controls for radiation-induced carotid stenosis","volume":"53","author":"Tallarita","year":"2011","unstructured":"121. Tallarita T, Oderich GS, Lanzino G, Cloft H, Kallmes D, Bower TC, et al.Outcomes of carotid artery stenting versus historical surgical controls for radiation-induced carotid stenosis. J Vasc Surg. 2011;53(3):629-36 e1-5.","journal-title":"J Vasc Surg"},{"issue":"1","key":"key20210928102019_B122","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jvs.2006.08.083","article-title":"Radiation arteritis: a contraindication to carotid stenting?","volume":"45","author":"Protack","year":"2007","unstructured":"122. Protack CD, Bakken AM, Saad WE, Illig KA, Waldman DL, Davies MG. Radiation arteritis: a contraindication to carotid stenting? J Vasc Surg. 2007;45(1):110-7.","journal-title":"J Vasc Surg"},{"issue":"3","key":"key20210928102019_B123","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/STROKEAHA.111.633743","article-title":"Stenting versus surgery in patients with carotid stenosis after previous cervical radiation therapy: systematic review and meta-analysis","volume":"43","author":"Fokkema","year":"2012","unstructured":"123. Fokkema M, den Hartog AG, Bots ML, van der Tweel I, Moll FL, de Borst GJ. Stenting versus surgery in patients with carotid stenosis after previous cervical radiation therapy: systematic review and meta-analysis. Stroke. 2012;43(3):793-801.","journal-title":"Stroke"},{"issue":"11","key":"key20210928102019_B124","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1177\/000313481608201125","article-title":"Percutaneous Treatment of Superficial Femoral Artery Stenosis Secondary to Radiation Arteritis","volume":"82","author":"Pham","year":"2016","unstructured":"124. Pham HD, Prather MG, Rush DS. Percutaneous Treatment of Superficial Femoral Artery Stenosis Secondary to Radiation Arteritis. Am Surg. 2016;82(11):1098-100.","journal-title":"Am Surg"},{"issue":"4","key":"key20210928102019_B125","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0360-3016(02)04156-1","article-title":"Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution","volume":"55","author":"Lind","year":"2003","unstructured":"125. Lind PA, Pagnanelli R, Marks LB, Borges-Neto S, Hu C, Zhou SM, et al.Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. Int J Radiat Oncol Biol Phys. 2003;55(4):914-20.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"key20210928102019_B126","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0360-3016(00)01531-5","article-title":"Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results","volume":"49","author":"Hardenbergh","year":"2001","unstructured":"126. Hardenbergh PH, Munley MT, Bentel GC, Kedem R, Borges-Neto S, Hollis D, et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys. 2001;49(4):1023-8.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"key20210928102019_B127","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3949\/ccjm.83a.15104","article-title":"Radiation-induced heart disease: A practical guide to diagnosis and management","volume":"83","author":"Donnellan","year":"2016","unstructured":"127. Donnellan E, Phelan D, McCarthy CP, Collier P, Desai M, Griffin B. Radiation-induced heart disease: A practical guide to diagnosis and management. Cleve Clin J Med. 2016;83(12):914-22.","journal-title":"Cleve Clin J Med"},{"issue":"3","key":"key20210928102019_B128","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1053-4296(03)00026-2","article-title":"Radiation-associated cardiovascular disease: manifestations and management","volume":"13","author":"Adams","year":"2003","unstructured":"128. Adams MJ, Lipshultz SE, Schwartz C, Fajardo LF, Coen V, Constine LS. Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat Oncol. 2003;13(3):346-56.","journal-title":"Semin Radiat Oncol"},{"issue":"8","key":"key20210928102019_B129","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ehjci\/jet123","article-title":"Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association os Cardiovascular Imaging and the American Society of Echocardiography","volume":"14","author":"Lancellotti","year":"2013","unstructured":"129. Lancellotti P, Nkomo VT, Badano LP, Bergler-Klein J, Bogaert J, Davin L, et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association os Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 2013; 14(8):721-40.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"22","key":"key20210928102019_B130","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1002\/cncr.28925","article-title":"Coronary artery disease detected by coronary computed tomography angiography in adult survivors of childhood Hodgkin lymphoma","volume":"120","author":"Mulrooney","year":"2014","unstructured":"130. Mulrooney DA, Nunnery SE, Armstrong GT, Ness KK, Srivastava D, Donovan FD, et al. Coronary artery disease detected by coronary computed tomography angiography in adult survivors of childhood Hodgkin lymphoma. Cancer. 2014;120(22):3536-44.","journal-title":"Cancer"},{"issue":"1","key":"key20210928102019_B131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijrobp.2014.01.021","article-title":"Prospective coronary heart disease screening in asymptomatic Hodgkin lymphoma patients using coronary computed tomography angiography: results and risk factor analysis","volume":"89","author":"Girinsky","year":"2014","unstructured":"131. Girinsky T, M\u2019Kacher R, Lessard N, Koscielny S, Elfassy E, Raoux F, et al. Prospective coronary heart disease screening in asymptomatic Hodgkin lymphoma patients using coronary computed tomography angiography: results and risk factor analysis. Int J Radiat Oncol Biol Phys. 2014;89(1):59-66.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"key20210928102019_B132","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2017.09.008","article-title":"Different manifestation of irradiation induced coronary artery disease detected with coronary computed tomography compared with matched non-irradiated controls","volume":"125","author":"van Rosendael","year":"2017","unstructured":"132. van Rosendael AR, Daniels LA, Dimitriu-Leen AC, Smit JM, van Rosendael PJ, Schalij MJ, et al. Different manifestation of irradiation induced coronary artery disease detected with coronary computed tomography compared with matched non-irradiated controls. Radiother Oncol. 2017;125(1):55-61.","journal-title":"Radiother Oncol"},{"issue":"9814","key":"key20210928102019_B133","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(11)61335-4","article-title":"Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial","volume":"379","author":"Greenwood","year":"2012","unstructured":"133. Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Colin C Everett CC, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet, 2012; 379(9814):453-60.","journal-title":"Lancet"},{"issue":"9","key":"key20210928102019_B134","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/2012.jama.11089","article-title":"Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults","volume":"308","author":"Schelbert","year":"2012","unstructured":"134. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, et al. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA 2012; 308(9): 890-6.","journal-title":"JAMA"},{"issue":"4","key":"key20210928102019_B135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jtho.2015.11.009","article-title":"The 2015 WHO Classification of Tumors of the Heart and Pericardium","volume":"11","author":"Burke","year":"2016","unstructured":"135. Burke A, Tavora F. The 2015 WHO Classification of Tumors of the Heart and Pericardium. J Thorac Oncol. 2016;11(4):441-52.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"key20210928102019_B136","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/ERP-16-0035","article-title":"Cardiac tumors: echo assessment","volume":"3","author":"Mankad","year":"2016","unstructured":"136. Mankad R, Herrmann J. Cardiac tumors: echo assessment. Echo Res Pract. 2016;3(4):R65-R77.","journal-title":"Echo Res Pract"},{"issue":"6","key":"key20210928102019_B137","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jcmg.2015.06.025","article-title":"Ultrasound Contrast Quantification for the Diagnosis of Intracardiac Masses","volume":"9","author":"Strachinaru","year":"2016","unstructured":"137. Strachinaru M, Damry N, Duttmann R, Wauthy P, Catez E, Lutea M, et al.Ultrasound Contrast Quantification for the Diagnosis of Intracardiac Masses. JACC Cardiovasc Imaging. 2016;9(6):747-50.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"key20210928102019_B138","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.ultrasmedbio.2015.05.010","article-title":"Usefulness of contrast perfusion echocardiography for differential diagnosis of cardiac masses","volume":"41","author":"Tang","year":"2015","unstructured":"138. Tang QY, Guo LD, Wang WX, Zhou W, Liu YN, Liu HY, et al.Usefulness of contrast perfusion echocardiography for differential diagnosis of cardiac masses. Ultrasound Med Biol. 2015;41(9):2382-90.","journal-title":"Ultrasound Med Biol"},{"issue":"6","key":"key20210928102019_B139","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.euje.2005.02.006","article-title":"Different deformation patterns in intracardiac tumors","volume":"6","author":"Ganame","year":"2005","unstructured":"139. Ganame J, D\u2019Hooge J, Mertens L. Different deformation patterns in intracardiac tumors. Eur J Echocardiogr. 2005;6(6):461-4.","journal-title":"Eur J Echocardiogr"},{"issue":"2","key":"key20210928102019_B140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1540-8175.2011.01627.x","article-title":"Real time three-dimensional echocardiography evaluation of intracardiac masses","volume":"29","author":"Zaragoza-Macias","year":"2012","unstructured":"140. Zaragoza-Macias E, Chen MA, Gill EA. Real time three-dimensional echocardiography evaluation of intracardiac masses. Echocardiography. 2012;29(2):207-19.","journal-title":"Echocardiography"},{"issue":"5","key":"key20210928102019_B141","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.02.019","article-title":"Calcified Amorphous Tumor Causing Shower Embolism to the Brain: A Case Report with Serial Echocardiographic and Neuroradiologic Images and a Review of the Literature","volume":"26","author":"Singu","year":"2017","unstructured":"141. Singu T, Inatomi Y, Yonehara T, Ando Y. Calcified Amorphous Tumor Causing Shower Embolism to the Brain: A Case Report with Serial Echocardiographic and Neuroradiologic Images and a Review of the Literature. J Stroke Cerebrovasc Dis. 2017;26(5):e85-e9.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"key20210928102019_B142","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/2150135117723904","article-title":"Cardiac Tumors in Pediatric Patients: A Systematic Review","volume":"8","author":"Tzani","year":"2017","unstructured":"142. Tzani A, Doulamis IP, Mylonas KS, Avgerinos DV, Nasioudis D. Cardiac Tumors in Pediatric Patients: A Systematic Review. World J Pediatr Congenit Heart Surg. 2017;8(5):624-32.","journal-title":"World J Pediatr Congenit Heart Surg"},{"issue":"4","key":"key20210928102019_B143","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1586\/14779072.2015.1024108","article-title":"Current diagnosis and management of cardiac myxomas","volume":"13","author":"Jain","year":"2015","unstructured":"143. Jain S, Maleszewski JJ, Stephenson CR, Klarich KW. Current diagnosis and management of cardiac myxomas. Expert Rev Cardiovasc Ther. 2015;13(4):369-75.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"key20210928102019_B144","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0002-8703(03)00249-7","article-title":"Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases","volume":"146","author":"Gowda","year":"2003","unstructured":"144. Gowda RM, Khan IA, Nair CK, Mehta NJ, Vasavada BC, Sacchi TJ. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J. 2003;146(3):404-10.","journal-title":"Am Heart J"},{"issue":"22","key":"key20210928102019_B145","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.jacc.2015.03.569","article-title":"Prognostic and Bioepidemiologic Implications of Papillary Fibroelastomas","volume":"65","author":"Tamin","year":"2015","unstructured":"145. Tamin SS, Maleszewski JJ, Scott CG, Khan SK, Edwards WD, Bruce CJ, et al.Prognostic and Bioepidemiologic Implications of Papillary Fibroelastomas. J Am Coll Cardiol. 2015;65(22):2420-9.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"key20210928102019_B146","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00059-014-4078-1","article-title":"Cardiac rhabdomyomas associated with tuberous sclerosis complex in children. From presentation to outcome","volume":"40","author":"Shen","year":"2015","unstructured":"146. Shen Q, Shen J, Qiao Z, Yao Q, Huang G, Hu X. Cardiac rhabdomyomas associated with tuberous sclerosis complex in children. From presentation to outcome. Herz. 2015;40(4):675-8.","journal-title":"Herz"},{"issue":"4","key":"key20210928102019_B147","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1148\/rg.344135163","article-title":"Pediatric cardiac tumors: clinical and imaging features","volume":"34","author":"Tao","year":"2014","unstructured":"147. Tao TY, Yahyavi-Firouz-Abadi N, Singh GK, Bhalla S. Pediatric cardiac tumors: clinical and imaging features. Radiographics. 2014;34(4):1031-46.","journal-title":"Radiographics"},{"issue":"4","key":"key20210928102019_B148","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/PAF.0000000000000271","article-title":"Cardiac Tumors: Echocardiographic Diagnosis and Forensic Correlations","volume":"37","author":"Capotosto","year":"2016","unstructured":"148. Capotosto L, Elena G, Massoni F, De Sio S, Carnevale A, Ricci S, et al.Cardiac Tumors: Echocardiographic Diagnosis and Forensic Correlations. Am J Forensic Med Pathol. 2016;37(4):306-16.","journal-title":"Am J Forensic Med Pathol"},{"issue":"1","key":"key20210928102019_B149","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1017\/S1047951113002187","article-title":"Primitive intrapericardial teratoma associated with yolk sac tumour","volume":"25","author":"Cetrano","year":"2015","unstructured":"149. Cetrano E, Polito A, Carotti A. Primitive intrapericardial teratoma associated with yolk sac tumour. Cardiol Young. 2015;25(1):158-60.","journal-title":"Cardiol Young"},{"issue":"6","key":"key20210928102019_B150","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.athoracsur.2015.02.064","article-title":"Cardiac Hemangioma: A Comprehensive Analysis of 200 Cases","volume":"99","author":"Li","year":"2015","unstructured":"150. Li W, Teng P, Xu H, Ma L, Ni Y. Cardiac Hemangioma: A Comprehensive Analysis of 200 Cases. Ann Thorac Surg. 2015;99(6):2246-52.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"key20210928102019_B151","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.radcr.2016.08.002","article-title":"Multimodality imaging of a cardiac paraganglioma","volume":"11","author":"Semionov","year":"2016","unstructured":"151. Semionov A, Sayegh K. Multimodality imaging of a cardiac paraganglioma. Radiol Case Rep. 2016;11(4):277-81.","journal-title":"Radiol Case Rep"},{"key":"key20210928102019_B152","doi-asserted-by":"crossref","first-page":"90","DOI":"10.12659\/AJCR.907408","article-title":"Benign Pericardial Schwannoma: Case Report and Summary of Previously Reported Cases","volume":"19","author":"Almobarak","year":"2018","unstructured":"152. Almobarak AA, AlShammari A, Alhomoudi RI, Eshaq AM, Algain SM, Jensen EC, et al.Benign Pericardial Schwannoma: Case Report and Summary of Previously Reported Cases. Am J Case Rep. 2018;19:90-4.","journal-title":"Am J Case Rep"},{"issue":"25","key":"key20210928102019_B153","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1161\/CIRCULATIONAHA.115.016418","article-title":"Characteristics and Survival of Malignant Cardiac Tumors: A 40-Year Analysis of >500 Patients","volume":"132","author":"Oliveira","year":"2015","unstructured":"153. Oliveira GH, Al-Kindi SG, Hoimes C, Park SJ. Characteristics and Survival of Malignant Cardiac Tumors: A 40-Year Analysis of >500 Patients. Circulation. 2015;132(25):2395-402.","journal-title":"Circulation"},{"issue":"6","key":"key20210928102019_B154","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/COC.0000000000000106","article-title":"Primary Cardiac Sarcoma: 25-Year Cleveland Clinic Experience","volume":"39","author":"Randhawa","year":"2016","unstructured":"154. Randhawa JS, Budd GT, Randhawa M, Ahluwalia M, Jia X, Daw H, et al.Primary Cardiac Sarcoma: 25-Year Cleveland Clinic Experience. Am J Clin Oncol. 2016;39(6):593-9.","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"key20210928102019_B155","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/echo.13060","article-title":"Echocardiographic Features of Cardiac Angiosarcomas: The Mayo Clinic Experience (1976-2013)","volume":"33","author":"Kupsky","year":"2016","unstructured":"155. Kupsky DF, Newman DB, Kumar G, Maleszewski JJ, Edwards WD, Klarich KW. Echocardiographic Features of Cardiac Angiosarcomas: The Mayo Clinic Experience (1976-2013). Echocardiography. 2016;33(2):186-92.","journal-title":"Echocardiography"},{"issue":"2","key":"key20210928102019_B156","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.jvca.2018.02.010","article-title":"Cardiac Undifferentiated Pleomorphic Sarcoma Mimicking Left Atrial Myxoma","volume":"33","author":"Valles-Torres","year":"2019","unstructured":"156. Valles-Torres J, Izquierdo-Villarroya MB, Vallejo-Gil JM, Casado-Dominguez JM, Roche Latasa AB, Auquilla-Clavijo P. Cardiac Undifferentiated Pleomorphic Sarcoma Mimicking Left Atrial Myxoma. J Cardiothorac Vasc Anesth. 2019;33(2):493-6.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"8","key":"key20210928102019_B157","doi-asserted-by":"crossref","first-page":"1073 e7","DOI":"10.1016\/j.echo.2006.04.006","article-title":"Primary cardiac lymphoma: diagnosis and treatment guided by transesophageal echocardiogram perfusion imaging","volume":"19","author":"Jang","year":"2006","unstructured":"157. Jang JJ, Danik S, Goldman M. Primary cardiac lymphoma: diagnosis and treatment guided by transesophageal echocardiogram perfusion imaging. J Am Soc Echocardiogr. 2006;19(8):1073 e7-9.","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"key20210928102019_B158","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1148\/rg.336135512","article-title":"Primary pericardial tumors","volume":"33","author":"Restrepo","year":"2013","unstructured":"158. Restrepo CS, Vargas D, Ocazionez D, Martinez-Jimenez S, Betancourt Cuellar SL, Gutierrez FR. Primary pericardial tumors. Radiographics. 2013;33(6):1613-30.","journal-title":"Radiographics"},{"issue":"5","key":"key20210928102019_B159","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.canep.2015.07.007","article-title":"Malignant tumors of the heart","volume":"39","author":"Hudzik","year":"2015","unstructured":"159. Hudzik B, Miszalski-Jamka K, Glowacki J, Lekston A, Gierlotka M, Zembala M, et al.Malignant tumors of the heart. Cancer Epidemiol. 2015;39(5):665-72.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"key20210928102019_B160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/jcp.2005.035105","article-title":"Cardiac metastases","volume":"60","author":"Bussani","year":"2007","unstructured":"160. Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastases. J Clin Pathol. 2007;60(1):27-34.","journal-title":"J Clin Pathol"},{"issue":"1","key":"key20210928102019_B161","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12885-018-4070-x","article-title":"Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment","volume":"18","author":"Burazor","year":"2018","unstructured":"161. Burazor I, Aviel-Ronen S, Imazio M, Goitein O, Perelman M, Shelestovich N, et al.Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment. BMC Cancer. 2018;18(1):202.","journal-title":"BMC Cancer"},{"issue":"4","key":"key20210928102019_B162","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2217\/fca.15.10","article-title":"Malignant cardiac tumors: diagnosis and treatment","volume":"11","author":"Lestuzzi","year":"2015","unstructured":"162. Lestuzzi C, De Paoli A, Baresic T, Miolo G, Buonadonna A. Malignant cardiac tumors: diagnosis and treatment. Future Cardiol. 2015;11(4):485-500.","journal-title":"Future Cardiol"},{"issue":"1","key":"key20210928102019_B163","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007829","article-title":"Assessment of Cardiac Masses by Cardiac Magnetic Resonance Imaging: Histological Correlation and Clinical Outcomes","volume":"8","author":"Mousavi","year":"2019","unstructured":"163. Mousavi N, Cheezum MK, Aghayev A, Padera R, Vita T, Steigner M, et al.Assessment of Cardiac Masses by Cardiac Magnetic Resonance Imaging: Histological Correlation and Clinical Outcomes. J Am Heart Assoc. 2019;8(1):e007829.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"key20210928102019_B164","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jcmg.2014.05.009","article-title":"Value of CMR for the differential diagnosis of cardiac masses","volume":"7","author":"Pazos-Lopez","year":"2014","unstructured":"164. Pazos-Lopez P, Pozo E, Siqueira ME, Garcia-Lunar I, Cham M, Jacobi A, et al.Value of CMR for the differential diagnosis of cardiac masses. JACC Cardiovasc Imaging. 2014;7(9):896-905.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"key20210928102019_B165","doi-asserted-by":"crossref","first-page":"1912 e2","DOI":"10.1016\/j.jtcvs.2018.09.057","article-title":"Differentiating benign from malignant cardiac tumors with cardiac magnetic resonance imaging","volume":"157","author":"Kassi","year":"2019","unstructured":"165. Kassi M, Polsani V, Schutt RC, Wong S, Nabi F, Reardon MJ, et al.Differentiating benign from malignant cardiac tumors with cardiac magnetic resonance imaging. J Thorac Cardiovasc Surg. 2019;157(5):1912-22 e2.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20210928102019_B166","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ijcard.2015.10.111","article-title":"Cardiac myxoma imaging features and tissue characteristics at cardiovascular magnetic resonance","volume":"202","author":"Colin","year":"2016","unstructured":"166. Colin GC, Dymarkowski S, Gerber B, Michoux N, Bogaert J. Cardiac myxoma imaging features and tissue characteristics at cardiovascular magnetic resonance. Int J Cardiol. 2016;202:950-1.","journal-title":"Int J Cardiol"},{"issue":"2","key":"key20210928102019_B167","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2214\/AJR.08.1895","article-title":"Cardiac tumors: optimal cardiac MR sequences and spectrum of imaging appearances","volume":"193","author":"O\u2019Donnell","year":"2009","unstructured":"167. O\u2019Donnell DH, Abbara S, Chaithiraphan V, Yared K, Killeen RP, Cury RC, et al.Cardiac tumors: optimal cardiac MR sequences and spectrum of imaging appearances. AJR Am J Roentgenol. 2009;193(2):377-87.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"key20210928102019_B168","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1148\/rg.255045721","article-title":"MR imaging of cardiac tumors","volume":"25","author":"Sparrow","year":"2005","unstructured":"168. Sparrow PJ, Kurian JB, Jones TR, Sivananthan MU. MR imaging of cardiac tumors. Radiographics. 2005;25(5):1255-76.","journal-title":"Radiographics"},{"issue":"3","key":"key20210928102019_B169","first-page":"263","article-title":"Magnetic resonance imaging evaluation of cardiac masses","volume":"101","author":"Braggion-Santos","year":"2013","unstructured":"169. Braggion-Santos MF, Koenigkam-Santos M, Teixeira SR, Volpe GJ, Trad HS, Schmidt A. Magnetic resonance imaging evaluation of cardiac masses. Arq Bras Cardiol. 2013;101(3):263-72.","journal-title":"Arq Bras Cardiol"},{"issue":"10","key":"key20210928102019_B170","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jcmg.2014.08.002","article-title":"CMR in the assessment of cardiac masses: primary malignant tumors","volume":"7","author":"Esposito","year":"2014","unstructured":"170. Esposito A, De Cobelli F, Ironi G, Marra P, Canu T, Mellone R, et al.CMR in the assessment of cardiac masses: primary malignant tumors. JACC Cardiovasc Imaging. 2014;7(10):1057-61.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"key20210928102019_B171","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/14779072.2014.872031","article-title":"Cardiac tumors: the role of cardiovascular imaging","volume":"12","author":"Bhattacharyya","year":"2014","unstructured":"171. Bhattacharyya S, Khattar RS, Gujral DM, Senior R. Cardiac tumors: the role of cardiovascular imaging. Expert Rev Cardiovasc Ther. 2014;12(1):37-43.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"key20210928102019_B172","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2967\/jnumed.111.095364","article-title":"Differentiation of malignant and benign cardiac tumors using 18F-FDG PET\/CT","volume":"53","author":"Rahbar","year":"2012","unstructured":"172. Rahbar K, Seifarth H, Schafers M, Stegger L, Hoffmeier A, Spieker T, et al.Differentiation of malignant and benign cardiac tumors using 18F-FDG PET\/CT. J Nucl Med. 2012;53(6):856-63.","journal-title":"J Nucl Med"},{"issue":"1","key":"key20210928102019_B173","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCIMAGING.109.886846","article-title":"Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI","volume":"3","author":"Bhattacharyya","year":"2010","unstructured":"173. Bhattacharyya S, Toumpanakis C, Burke M, Taylor AM, Caplin ME, Davar J. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI. Circ Cardiovasc Imaging. 2010;3(1):103-11.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"key20210928102019_B174","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ahj.2014.03.018","article-title":"Carcinoid heart disease: current understanding and future directions","volume":"167","author":"Patel","year":"2014","unstructured":"174. Patel C, Mathur M, Escarcega RO, Bove AA. Carcinoid heart disease: current understanding and future directions. Am Heart J. 2014;167(6):789-95.","journal-title":"Am Heart J"},{"issue":"10","key":"key20210928102019_B175","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2016.12.030","article-title":"Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement","volume":"69","author":"Davar","year":"2017","unstructured":"175. Davar J, Connolly HM, Caplin ME, Pavel M, Zacks J, Bhattacharyya S, et al.Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement. J Am Coll Cardiol. 2017;69(10):1288-304.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"key20210928102019_B176","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/bjc.2014.468","article-title":"Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality","volume":"111","author":"Dobson","year":"2014","unstructured":"176. Dobson R, Burgess MI, Valle JW, Pritchard DM, Vora J, Wong C, et al.Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality. Br J Cancer. 2014;111(9):1703-9.","journal-title":"Br J Cancer"},{"issue":"6","key":"key20210928102019_B177","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.0007-1323.2001.01798.x","article-title":"Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome","volume":"88","author":"Westberg","year":"2001","unstructured":"177. Westberg G, Wangberg B, Ahlman H, Bergh CH, Beckman-Suurkula M, Caidahl K. Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome. Br J Surg. 2001;88(6):865-72.","journal-title":"Br J Surg"},{"issue":"2","key":"key20210928102019_B178","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000360767","article-title":"Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease","volume":"99","author":"Dobson","year":"2014","unstructured":"178. Dobson R, Cuthbertson DJ, Jones J, Valle JW, Keevil B, Chadwick C, et al.Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease. Neuroendocrinology. 2014;99(2):85-93.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"key20210928102019_B179","first-page":"71","article-title":"Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction","volume":"109","author":"Mesquita","year":"2017","unstructured":"179. Mesquita ET, Jorge AJL, Souza CVJ, Andrade TR. Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction. Arq Bras Cardiol. 2017;109(1):71-80.","journal-title":"Arq Bras Cardiol"},{"issue":"17","key":"key20210928102019_B180","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release","volume":"72","author":"Sperry","year":"2018","unstructured":"180. Sperry BW, Reyes BA, Ikram A, Donnelly JP, Phelan D, Jaber WA, et al.Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release. J Am Coll Cardiol. 2018;72(17):2040-50.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"key20210928102019_B181","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2559.2007.02658.x","article-title":"Bone marrow findings correlate with clinical outcome in systemic AL amyloidosis patients","volume":"50","author":"Hasserjian","year":"2007","unstructured":"181. Hasserjian RP, Goodman HJ, Lachmann HJ, Muzikansky A, Hawkins PN. Bone marrow findings correlate with clinical outcome in systemic AL amyloidosis patients. Histopathology. 2007;50(5):567-73.","journal-title":"Histopathology"},{"issue":"6","key":"key20210928102019_B182","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","unstructured":"182. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349(6):583-96.","journal-title":"N Engl J Med"},{"issue":"2","key":"key20210928102019_B183","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000881","article-title":"Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis","volume":"5","author":"Agha","year":"2018","unstructured":"183. Agha AM, Parwani P, Guha A, Durand JB, Iliescu CA, Hassan S, et al.Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis. Open Heart. 2018;5(2):e000881.","journal-title":"Open Heart"},{"issue":"2","key":"key20210928102019_B184","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12350-013-9800-5","article-title":"Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques","volume":"21","author":"Aljaroudi","year":"2014","unstructured":"184. Aljaroudi WA, Desai MY, Tang WH, Phelan D, Cerqueira MD, Jaber WA. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques. J Nucl Cardiol. 2014;21(2):271-83.","journal-title":"J Nucl Cardiol"},{"issue":"12","key":"key20210928102019_B185","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy","volume":"68","author":"Falk","year":"2016","unstructured":"185. Falk RH, Alexander KM, Liao R, Dorbala S. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. J Am Coll Cardiol. 2016;68(12):1323-41.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"key20210928102019_B186","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.acvd.2013.06.051","article-title":"Cardiac amyloidosis: updates in diagnosis and management","volume":"106","author":"Mohty","year":"2013","unstructured":"186. Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, et al.Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis. 2013;106(10):528-40.","journal-title":"Arch Cardiovasc Dis"},{"issue":"4","key":"key20210928102019_B187","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0735-1097(85)80475-7","article-title":"Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival","volume":"6","author":"Cueto-Garcia","year":"1985","unstructured":"187. Cueto-Garcia L, Reeder GS, Kyle RA, Wood DL, Seward JB, Naessens J, et al.Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol. 1985;6(4):737-43.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"key20210928102019_B188","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005588","article-title":"Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis: A Head-to-Head Comparison of Deformation and Nondeformation Parameters","volume":"10","author":"Pagourelias","year":"2017","unstructured":"188. Pagourelias ED, Mirea O, Duchenne J, Van Cleemput J, Delforge M, Bogaert J, et al.Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis: A Head-to-Head Comparison of Deformation and Nondeformation Parameters. Circ Cardiovasc Imaging. 2017;10(3):e005588.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"key20210928102019_B189","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jcmg.2016.04.008","article-title":"Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System","volume":"10","author":"Barros-Gomes","year":"2017","unstructured":"189. Barros-Gomes S, Williams B, Nhola LF, Grogan M, Maalouf JF, Dispenzieri A, et al.Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System. JACC Cardiovasc Imaging. 2017;10(4):398-407.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"19","key":"key20210928102019_B190","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","unstructured":"190. Phelan D, Collier P, Thavendiranathan P, Popovic ZB, Hanna M, Plana JC, et al.Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98(19):1442-8.","journal-title":"Heart"},{"issue":"10","key":"key20210928102019_B191","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/heartjnl-2015-308657","article-title":"Prognostic implication of relative regional strain ratio in cardiac amyloidosis","volume":"102","author":"Senapati","year":"2016","unstructured":"191. Senapati A, Sperry BW, Grodin JL, Kusunose K, Thavendiranathan P, Jaber W, et al.Prognostic implication of relative regional strain ratio in cardiac amyloidosis. Heart. 2016;102(10):748-54.","journal-title":"Heart"},{"issue":"1","key":"key20210928102019_B192","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.echo.2017.08.017","article-title":"Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation","volume":"31","author":"Pun","year":"2018","unstructured":"192. Pun SC, Landau HJ, Riedel ER, Jordan J, Yu AF, Hassoun H, et al.Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation. J Am Soc Echocardiogr. 2018;31(1):64-70.","journal-title":"J Am Soc Echocardiogr"},{"issue":"12","key":"key20210928102019_B193","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115910","article-title":"Predictive value of assessing diastolic strain rate on survival in cardiac amyloidosis patients with preserved ejection fraction","volume":"9","author":"Liu","year":"2014","unstructured":"193. Liu D, Hu K, Stork S, Herrmann S, Kramer B, Cikes M, et al.Predictive value of assessing diastolic strain rate on survival in cardiac amyloidosis patients with preserved ejection fraction. PLoS One. 2014;9(12):e115910.","journal-title":"PLoS One"},{"issue":"5","key":"key20210928102019_B194","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006588","article-title":"Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis","volume":"11","author":"Milani","year":"2018","unstructured":"194. Milani P, Dispenzieri A, Scott CG, Gertz MA, Perlini S, Mussinelli R, et al.Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis. Circ Cardiovasc Imaging. 2018;11(5):e006588.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"18","key":"key20210928102019_B195","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/CIRCULATIONAHA.108.785014","article-title":"Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis","volume":"119","author":"Feng","year":"2009","unstructured":"195. Feng D, Syed IS, Martinez M, Oh JK, Jaffe AS, Grogan M, et al.Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis. Circulation. 2009;119(18):2490-7.","journal-title":"Circulation"},{"issue":"5","key":"key20210928102019_B196","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/hrt.74.5.541","article-title":"Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation","volume":"74","author":"Dubrey","year":"1995","unstructured":"196. Dubrey S, Pollak A, Skinner M, Falk RH. Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br Heart J. 1995;74(5):541-4.","journal-title":"Br Heart J"},{"issue":"7","key":"key20210928102019_B197","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11912-017-0607-4","article-title":"Cardiac Amyloidosis: Diagnosis and Treatment Strategies","volume":"19","author":"Tuzovic","year":"2017","unstructured":"197. Tuzovic M, Yang EH, Baas AS, Depasquale EC, Deng MC, Cruz D, et al.Cardiac Amyloidosis: Diagnosis and Treatment Strategies. Curr Oncol Rep. 2017;19(7):46.","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"key20210928102019_B198","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis","volume":"3","author":"Syed","year":"2010","unstructured":"198. Syed IS, Glockner JF, Feng D, Araoz PA, Martinez MW, Edwards WD, et al.Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging. 2010;3(2):155-64.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"key20210928102019_B199","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jcmg.2009.08.008","article-title":"Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis","volume":"2","author":"Austin","year":"2009","unstructured":"199. Austin BA, Tang WH, Rodriguez ER, Tan C, Flamm SD, Taylor DO, et al.Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging. 2009;2(12):1369-77.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"key20210928102019_B200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis","volume":"7","author":"Dungu","year":"2014","unstructured":"200. Dungu JN, Valencia O, Pinney JH, Gibbs SD, Rowczenio D, Gilbertson JA, et al.CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7(2):133-42.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"key20210928102019_B201","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis","volume":"6","author":"Karamitsos","year":"2013","unstructured":"201. Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, et al.Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6(4):488-97.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"key20210928102019_B202","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","unstructured":"202. Banypersad SM, Fontana M, Maestrini V, Sado DM, Captur G, Petrie A, et al.T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J. 2015;36(4):244-51.","journal-title":"Eur Heart J"},{"key":"key20210928102019_B203","year":"2020","unstructured":"203. Amyloidosis Support Groups - HOW FAR ARE YOU FROM TREATMENT AND SUPPORT? [Acessado em 04\/07\/2020]. Dispon\u00edvel em: https:\/\/www.amyloidosissupport.org\/. 2020.","journal-title":"Amyloidosis Support Groups - HOW FAR ARE YOU FROM TREATMENT AND SUPPORT?"},{"issue":"24","key":"key20210928102019_B204","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","author":"Gillmore","year":"2016","unstructured":"204. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al.Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016;133(24):2404-12.","journal-title":"Circulation"},{"issue":"1","key":"key20210928102019_B205","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis","volume":"4","author":"Merlini","year":"2018","unstructured":"205. Merlini G, Dispenzieri A, Sanchorawala V, Schonland SO, Palladini G, Hawkins PN, et al.Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers. 2018;4(1):38.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"key20210928102019_B206","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2018.022","article-title":"Light Chain Amyloidosis","volume":"10","author":"Milani","year":"2018","unstructured":"206. Milani P, Merlini G, Palladini G. Light Chain Amyloidosis. Mediterr J Hematol Infect Dis. 2018;10(1):e2018022.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"4","key":"key20210928102019_B207","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/13506129.2011.614295","article-title":"The relative amounts of plasma transthyretin forms in familial transthyretin amyloidosis: a quantitative analysis by Fourier transform ion-cyclotron resonance mass spectrometry","volume":"18","author":"Ribeiro-Silva","year":"2011","unstructured":"207. Ribeiro-Silva C, Gilberto S, Gomes RA, Mateus E, Monteiro E, Barroso E, et al.The relative amounts of plasma transthyretin forms in familial transthyretin amyloidosis: a quantitative analysis by Fourier transform ion-cyclotron resonance mass spectrometry. Amyloid. 2011;18(4):191-9.","journal-title":"Amyloid"},{"issue":"10","key":"key20210928102019_B208","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ejheart.2008.07.008","article-title":"Long-term prognosis of the transient left ventricular dysfunction syndrome (Tako-Tsubo cardiomyopathy): focus on malignancies","volume":"10","author":"Burgdorf","year":"2008","unstructured":"208. Burgdorf C, Kurowski V, Bonnemeier H, Schunkert H, Radke PW. Long-term prognosis of the transient left ventricular dysfunction syndrome (Tako-Tsubo cardiomyopathy): focus on malignancies. Eur J Heart Fail. 2008;10(10):1015-9.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"key20210928102019_B209","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.amjcard.2017.09.009","article-title":"Stress-Induced Cardiomyopathy in Cancer Patients","volume":"120","author":"Giza","year":"2017","unstructured":"209. Giza DE, Lopez-Mattei J, Vejpongsa P, Munoz E, Iliescu G, Kitkungvan D, et al.Stress-Induced Cardiomyopathy in Cancer Patients. Am J Cardiol. 2017;120(12):2284-8.","journal-title":"Am J Cardiol"},{"issue":"7","key":"key20210928102019_B210","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1540-8175.2011.01430.x","article-title":"Global and regional myocardial function quantification in Takotsubo cardiomyopathy in comparison to acute anterior myocardial infarction using two-dimensional (2D) strain echocardiography","volume":"28","author":"Heggemann","year":"2011","unstructured":"210. Heggemann F, Hamm K, Kaelsch T, Sueselbeck T, Papavassiliu T, Borggrefe M, et al.Global and regional myocardial function quantification in Takotsubo cardiomyopathy in comparison to acute anterior myocardial infarction using two-dimensional (2D) strain echocardiography. Echocardiography. 2011;28(7):715-9.","journal-title":"Echocardiography"},{"issue":"2","key":"key20210928102019_B211","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1378\/chest.99.2.382","article-title":"Catecholamine-induced cardiomyopathy in multiple endocrine neoplasia. A histologic, ultrastructural, and biochemical study","volume":"99","author":"Frustaci","year":"1991","unstructured":"211. Frustaci A, Loperfido F, Gentiloni N, Caldarulo M, Morgante E, Russo MA. Catecholamine-induced cardiomyopathy in multiple endocrine neoplasia. A histologic, ultrastructural, and biochemical study. Chest. 1991;99(2):382-5.","journal-title":"Chest"},{"issue":"2","key":"key20210928102019_B212","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ajh.23628","article-title":"Diagnosis and treatment of cancer-related anemia","volume":"89","author":"Gilreath","year":"2014","unstructured":"212. Gilreath JA, Stenehjem DD, Rodgers GM. Diagnosis and treatment of cancer-related anemia. Am J Hematol. 2014;89(2):203-12.","journal-title":"Am J Hematol"},{"issue":"5","key":"key20210928102019_B213","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/pbc.21663","article-title":"Myocardial iron overload in transfusion-dependent pediatric patients with acute leukemia","volume":"51","author":"Lutz","year":"2008","unstructured":"213. Lutz K, von Komorowski G, Durken M, Engelhardt R, Dinter DJ. Myocardial iron overload in transfusion-dependent pediatric patients with acute leukemia. Pediatr Blood Cancer. 2008;51(5):691-3.","journal-title":"Pediatr Blood Cancer"},{"key":"key20210928102019_B214","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0002-9343(62)90299-1","article-title":"Cardiac hemochromatosis simulating constrictive pericarditis","volume":"32","author":"Wasserman","year":"1962","unstructured":"214. Wasserman AJ, Richardson DW, Baird CL, Wyso EM. Cardiac hemochromatosis simulating constrictive pericarditis. Am J Med. 1962;32:316-23.","journal-title":"Am J Med"},{"issue":"6","key":"key20210928102019_B215","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s11739-017-1670-4","article-title":"Myocardial deformation in iron overload cardiomyopathy: speckle tracking imaging in a beta-thalassemia major population","volume":"12","author":"Di Odoardo","year":"2017","unstructured":"215. Di Odoardo LAF, Giuditta M, Cassinerio E, Roghi A, Pedrotti P, Vicenzi M, et al.Myocardial deformation in iron overload cardiomyopathy: speckle tracking imaging in a beta-thalassemia major population. Intern Emerg Med. 2017;12(6):799-809.","journal-title":"Intern Emerg Med"},{"issue":"9","key":"key20210928102019_B216","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/echo.13266","article-title":"Role of Three-Dimensional Speckle Tracking Echocardiography in the Quantification of Myocardial Iron Overload in Patients with Beta-Thalassemia Major","volume":"33","author":"Li","year":"2016","unstructured":"216. Li SJ, Hwang YY, Ha SY, Chan GC, Mok AS, Wong SJ, et al.Role of Three-Dimensional Speckle Tracking Echocardiography in the Quantification of Myocardial Iron Overload in Patients with Beta-Thalassemia Major. Echocardiography. 2016;33(9):1361-7.","journal-title":"Echocardiography"},{"issue":"1","key":"key20210928102019_B217","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MPH.0000000000000444","article-title":"Iron Overload in Survivors of Childhood Cancer","volume":"38","author":"Schempp","year":"2016","unstructured":"217. Schempp A, Lee J, Kearney S, Mulrooney DA, Smith AR. Iron Overload in Survivors of Childhood Cancer. J Pediatr Hematol Oncol. 2016;38(1):27-31.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"key20210928102019_B218","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2141.2011.08749.x","article-title":"Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes","volume":"154","author":"Roy","year":"2011","unstructured":"218. Roy NB, Myerson S, Schuh AH, Bignell P, Patel R, Wainscoat JS, et al.Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes. Br J Haematol. 2011;154(4):521-4.","journal-title":"Br J Haematol"},{"issue":"10","key":"key20210928102019_B219","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2015.06.1332","article-title":"Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion","volume":"66","author":"El Haddad","year":"2015","unstructured":"219. El Haddad D, Iliescu C, Yusuf SW, William WN, Jr., Khair TH, Song J, et al.Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion. J Am Coll Cardiol. 2015;66(10):1119-28.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"key20210928102019_B220","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1586\/14779072.2015.1025754","article-title":"2015 update on the diagnosis and management of neoplastic pericardial disease","volume":"13","author":"Lestuzzi","year":"2015","unstructured":"220. Lestuzzi C, Berretta M, Tomkowski W. 2015 update on the diagnosis and management of neoplastic pericardial disease. Expert Rev Cardiovasc Ther. 2015;13(4):377-89.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"key20210928102019_B221","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jcmg.2010.04.009","article-title":"Multimodality imaging of pericardial diseases","volume":"3","author":"Yared","year":"2010","unstructured":"221. Yared K, Baggish AL, Picard MH, Hoffmann U, Hung J. Multimodality imaging of pericardial diseases. JACC Cardiovasc Imaging. 2010;3(6):650-60.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"16","key":"key20210928102019_B222","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009428","article-title":"Acute Pericarditis and Cancer Risk: A Matched Cohort Study Using Linked UK Primary and Secondary Care Data","volume":"7","author":"Sogaard","year":"2018","unstructured":"222. Sogaard KK, Sorensen HT, Smeeth L, Bhaskaran K. Acute Pericarditis and Cancer Risk: A Matched Cohort Study Using Linked UK Primary and Secondary Care Data. J Am Heart Assoc. 2018;7(16):e009428.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"key20210928102019_B223","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12947-018-0125-z","article-title":"Echocardiographic characteristics of primary malignant pericardial mesothelioma and outcomes analysis: a retrospective study","volume":"16","author":"Kong","year":"2018","unstructured":"223. Kong L, Li Z, Wang J, Lv X. Echocardiographic characteristics of primary malignant pericardial mesothelioma and outcomes analysis: a retrospective study. Cardiovasc Ultrasound. 2018;16(1):7.","journal-title":"Cardiovasc Ultrasound"},{"issue":"20","key":"key20210928102019_B224","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/heartjnl-2015-307907","article-title":"Systematic review of percutaneous interventions for malignant pericardial effusion","volume":"101","author":"Virk","year":"2015","unstructured":"224. Virk SA, Chandrakumar D, Villanueva C, Wolfenden H, Liou K, Cao C. Systematic review of percutaneous interventions for malignant pericardial effusion. Heart. 2015;101(20):1619-26.","journal-title":"Heart"},{"key":"key20210928102019_B225","author":"Brasil. Minist\u00e9rio da Sa\u00fadeInstituto Nacional de Cancer","year":"2020","unstructured":"225. Brasil. Minist\u00e9rio da Sa\u00fadeInstituto Nacional de Cancer. Estimativa 2020. [Acessado em 05\/07\/2020]. Dispon\u00edvel em: https:\/\/www.inca.gov.br. 2020.","journal-title":"Estimativa"},{"issue":"5","key":"key20210928102019_B226","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cvr\/cvz031","article-title":"Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment","volume":"115","author":"Chow","year":"2019","unstructured":"226. Chow EJ, Leger KJ, Bhatt NS, Mulrooney DA, Ross CJ, Aggarwal S, et al.Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment. Cardiovasc Res. 2019;115(5):922-34.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"key20210928102019_B227","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S1470-2045(14)70409-7","article-title":"Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"16","author":"Armenian","year":"2015","unstructured":"227. Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, et al.Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015;16(3):e123-36.","journal-title":"Lancet Oncol"},{"issue":"5","key":"key20210928102019_B228","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40272-014-0085-1","article-title":"Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers","volume":"16","author":"Lipshultz","year":"2014","unstructured":"228. Lipshultz SE, Diamond MB, Franco VI, Aggarwal S, Leger K, Santos MV, et al.Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers. Paediatr Drugs. 2014;16(5):373-89.","journal-title":"Paediatr Drugs"},{"issue":"24","key":"key20210928102019_B229","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management","volume":"53","author":"Yeh","year":"2009","unstructured":"229. Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. 2009;53(24):2231-47.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20210928102019_B230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/clpt.2013.201","article-title":"Topoisomerase 2beta: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity","volume":"95","author":"Vejpongsa","year":"2014","unstructured":"230. Vejpongsa P, Yeh ET. Topoisomerase 2beta: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity. Clin Pharmacol Ther. 2014;95(1):45-52.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"key20210928102019_B231","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2141.2004.04803.x","article-title":"Does anthracycline administration by infusion in children affect late cardiotoxicity?","volume":"124","author":"Levitt","year":"2004","unstructured":"231. Levitt GA, Dorup I, Sorensen K, Sullivan I. Does anthracycline administration by infusion in children affect late cardiotoxicity? Br J Haematol. 2004;124(4):463-8.","journal-title":"Br J Haematol"},{"issue":"9","key":"key20210928102019_B232","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/14740338.2018.1513488","article-title":"Cardiovascular safety of oncologic agents: A double-edged sword even in the era of targeted therapies - part 1","volume":"17","author":"Manolis","year":"2018","unstructured":"232. Manolis AA, Manolis TA, Mikhailidis DP, Manolis AS. Cardiovascular safety of oncologic agents: A double-edged sword even in the era of targeted therapies - part 1. Expert Opin Drug Saf. 2018;17(9):875-92.","journal-title":"Expert Opin Drug Saf"},{"issue":"21","key":"key20210928102019_B233","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1200\/JCO.2017.76.4647","article-title":"New Agents, Emerging Late Effects, and the Development of Precision Survivorship","volume":"36","author":"Chow","year":"2018","unstructured":"233. Chow EJ, Antal Z, Constine LS, Gardner R, Wallace WH, Weil BR, et al.New Agents, Emerging Late Effects, and the Development of Precision Survivorship. J Clin Oncol. 2018;36(21):2231-40.","journal-title":"J Clin Oncol"},{"key":"key20210928102019_B234","doi-asserted-by":"crossref","first-page":"b4606","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort","volume":"339","author":"Mulrooney","year":"2009","unstructured":"234. Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, et al.Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606.","journal-title":"BMJ"},{"issue":"1","key":"key20210928102019_B235","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11764-011-0186-6","article-title":"Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood","volume":"6","author":"Vandecruys","year":"2012","unstructured":"235. Vandecruys E, Mondelaers V, De Wolf D, Benoit Y, Suys B. Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood. J Cancer Surviv. 2012;6(1):95-101.","journal-title":"J Cancer Surviv"},{"issue":"4","key":"key20210928102019_B236","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00246-012-0539-6","article-title":"Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors study","volume":"34","author":"Landy","year":"2013","unstructured":"236. Landy DC, Miller TL, Lipsitz SR, Lopez-Mitnik G, Hinkle AS, Constine LS, et al.Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors study. Pediatr Cardiol. 2013;34(4):826-34.","journal-title":"Pediatr Cardiol"},{"issue":"9","key":"key20210928102019_B237","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ng.3374","article-title":"A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer","volume":"47","author":"Aminkeng","year":"2015","unstructured":"237. Aminkeng F, Bhavsar AP, Visscher H, Rassekh SR, Li Y, Lee JW, et al.A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer. Nat Genet. 2015;47(9):1079-84.","journal-title":"Nat Genet"},{"issue":"1","key":"key20210928102019_B238","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12012-015-9307-1","article-title":"Anthracycline-Related Cardiotoxicity in Patients with Acute Myeloid Leukemia and Down Syndrome: A Literature Review","volume":"16","author":"Hefti","year":"2016","unstructured":"238. Hefti E, Blanco JG. Anthracycline-Related Cardiotoxicity in Patients with Acute Myeloid Leukemia and Down Syndrome: A Literature Review. Cardiovasc Toxicol. 2016;16(1):5-13.","journal-title":"Cardiovasc Toxicol"},{"issue":"8","key":"key20210928102019_B239","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1007\/s00246-015-1203-8","article-title":"Abnormal Myocardial Strain Indices in Children Receiving Anthracycline Chemotherapy","volume":"36","author":"Pignatelli","year":"2015","unstructured":"239. Pignatelli RH, Ghazi P, Reddy SC, Thompson P, Cui Q, Castro J, et al.Abnormal Myocardial Strain Indices in Children Receiving Anthracycline Chemotherapy. Pediatr Cardiol. 2015;36(8):1610-6.","journal-title":"Pediatr Cardiol"},{"issue":"8","key":"key20210928102019_B240","doi-asserted-by":"crossref","first-page":"842 e6","DOI":"10.1016\/j.echo.2012.05.004","article-title":"The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy","volume":"25","author":"Colan","year":"2012","unstructured":"240. Colan SD, Shirali G, Margossian R, Gallagher D, Altmann K, Canter C, et al.The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy. J Am Soc Echocardiogr. 2012;25(8):842-54 e6.","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"key20210928102019_B241","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00247-013-2656-7","article-title":"Pediatric nuclear medicine and pediatric radiology: modalities, image quality, dosimetry and correlative imaging: new strategies","volume":"43","author":"Roca-Bielsa","year":"2013","unstructured":"241. Roca-Bielsa I, Vlajkovic M. Pediatric nuclear medicine and pediatric radiology: modalities, image quality, dosimetry and correlative imaging: new strategies. Pediatr Radiol. 2013;43(4):391-2.","journal-title":"Pediatr Radiol"},{"issue":"6","key":"key20210928102019_B242","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/j.nuclcard.2006.08.007","article-title":"Equilibrium radionuclide angiocardiography","volume":"13","author":"Corbett","year":"2006","unstructured":"242. Corbett JR, Akinboboye OO, Bacharach SL, Borer JS, Botvinick EH, DePuey EG, et al.Equilibrium radionuclide angiocardiography. J Nucl Cardiol. 2006;13(6):e56-79.","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"key20210928102019_B243","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.106.677625","article-title":"Stress-related cardiomyopathy syndromes","volume":"118","author":"Bybee","year":"2008","unstructured":"243. Bybee KA, Prasad A. Stress-related cardiomyopathy syndromes. Circulation. 2008;118(4):397-409.","journal-title":"Circulation"},{"key":"key20210928102019_B244","doi-asserted-by":"crossref","first-page":"317659","DOI":"10.4061\/2011\/317659","article-title":"Radiation-induced heart disease: a clinical update","volume":"2011","author":"Yusuf","year":"2011","unstructured":"244. Yusuf SW, Sami S, Daher IN. Radiation-induced heart disease: a clinical update. Cardiol Res Pract. 2011;2011:317659.","journal-title":"Cardiol Res Pract"},{"issue":"1","key":"key20210928102019_B245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JCO.2006.07.0805","article-title":"Screening for coronary artery disease after mediastinal irradiation for Hodgkin\u2019s disease","volume":"25","author":"Heidenreich","year":"2007","unstructured":"245. Heidenreich PA, Schnittger I, Strauss HW, Vagelos RH, Lee BK, Mariscal CS, et al.Screening for coronary artery disease after mediastinal irradiation for Hodgkin\u2019s disease. J Clin Oncol. 2007;25(1):43-9.","journal-title":"J Clin Oncol"},{"issue":"2","key":"key20210928102019_B246","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1542\/peds.2007-0575","article-title":"Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children\u2019s Oncology Group","volume":"121","author":"Shankar","year":"2008","unstructured":"246. Shankar SM, Marina N, Hudson MM, Hodgson DC, Adams MJ, Landier W, et al.Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children\u2019s Oncology Group. Pediatrics. 2008;121(2):e387-96.","journal-title":"Pediatrics"},{"issue":"15","key":"key20210928102019_B247","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.ejca.2006.04.014","article-title":"Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines","volume":"42","author":"van Dalen","year":"2006","unstructured":"247. van Dalen EC, van der Pal HJ, van den Bos C, Kok WE, Caron HN, Kremer LC. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines. Eur J Cancer. 2006;42(15):2549-53.","journal-title":"Eur J Cancer"},{"issue":"1","key":"key20210928102019_B248","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11764-015-0457-8","article-title":"Pregnancy-associated cardiomyopathy in survivors of childhood cancer","volume":"10","author":"Hines","year":"2016","unstructured":"248. Hines MR, Mulrooney DA, Hudson MM, Ness KK, Green DM, Howard SC, et al.Pregnancy-associated cardiomyopathy in survivors of childhood cancer. J Cancer Surviv. 2016;10(1):113-21.","journal-title":"J Cancer Surviv"},{"issue":"3","key":"key20210928102019_B249","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1067\/S0002-9378(03)00837-8","article-title":"Pregnancy outcome in women treated with doxorubicin for childhood cancer","volume":"189","author":"Bar","year":"2003","unstructured":"249. Bar J, Davidi O, Goshen Y, Hod M, Yaniv I, Hirsch R. Pregnancy outcome in women treated with doxorubicin for childhood cancer. Am J Obstet Gynecol. 2003;189(3):853-7.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"key20210928102019_B250","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacc.2016.11.040","article-title":"Cardiac Outcomes With Pregnancy After Cardiotoxic Therapy for Childhood Cancer","volume":"69","author":"Thompson","year":"2017","unstructured":"250. Thompson KA, Hildebrandt MA, Ater JL. Cardiac Outcomes With Pregnancy After Cardiotoxic Therapy for Childhood Cancer. J Am Coll Cardiol. 2017;69(5):594-5.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"key20210928102019_B251","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jacc.2011.04.014","article-title":"Pregnancy in patients with pre-existing cardiomyopathies","volume":"58","author":"Stergiopoulos","year":"2011","unstructured":"251. Stergiopoulos K, Shiang E, Bench T. Pregnancy in patients with pre-existing cardiomyopathies. J Am Coll Cardiol. 2011;58(4):337-50.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"key20210928102019_B252","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/pbc.21734","article-title":"Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer","volume":"51","author":"Athale","year":"2008","unstructured":"252. Athale U, Siciliano S, Thabane L, Pai N, Cox S, Lathia A, et al.Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer. Pediatr Blood Cancer. 2008;51(6):792-7.","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"key20210928102019_B253","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/blood-2006-04-015511","article-title":"Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients","volume":"108","author":"Caruso","year":"2006","unstructured":"253. Caruso V, Iacoviello L, Di Castelnuovo A, Storti S, Mariani G, de Gaetano G, et al.Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood. 2006;108(7):2216-22.","journal-title":"Blood"},{"issue":"5","key":"key20210928102019_B254","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-2141.2008.07243.x","article-title":"Clinical features and outcome of pulmonary embolism in children","volume":"142","author":"Biss","year":"2008","unstructured":"254. Biss TT, Brandao LR, Kahr WH, Chan AK, Williams S. Clinical features and outcome of pulmonary embolism in children. Br J Haematol. 2008;142(5):808-18.","journal-title":"Br J Haematol"},{"issue":"29","key":"key20210928102019_B255","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1200\/JCO.2009.22.4584","article-title":"Impact of venous thromboembolism and anticoagulation on cancer and cancer survival","volume":"27","author":"Kuderer","year":"2009","unstructured":"255. Kuderer NM, Ortel TL, Francis CW. Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol. 2009;27(29):4902-11.","journal-title":"J Clin Oncol"},{"issue":"17","key":"key20210928102019_B256","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1002\/cncr.25199","article-title":"Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer","volume":"116","author":"Revel-Vilk","year":"2010","unstructured":"256. Revel-Vilk S, Yacobovich J, Tamary H, Goldstein G, Nemet S, Weintraub M, et al.Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer. Cancer. 2010;116(17):4197-205.","journal-title":"Cancer"},{"issue":"5","key":"key20210928102019_B257","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbmt.2016.01.023","article-title":"Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children\u2019s Oncology Group Report","volume":"22","author":"Chow","year":"2016","unstructured":"257. Chow EJ, Anderson L, Baker KS, Bhatia S, Guilcher GM, Huang JT, et al.Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children\u2019s Oncology Group Report. Biol Blood Marrow Transplant. 2016;22(5):782-95.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"key20210928102019_B258","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood-2011-01-331835","article-title":"Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)","volume":"118","author":"Armenian","year":"2011","unstructured":"258. Armenian SH, Sun CL, Kawashima T, Arora M, Leisenring W, Sklar CA, et al.Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood. 2011;118(5):1413-20.","journal-title":"Blood"},{"issue":"10","key":"key20210928102019_B259","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1182\/blood-2006-10-054924","article-title":"Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation","volume":"109","author":"Armand","year":"2007","unstructured":"259. Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP, et al.Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood. 2007;109(10):4586-8.","journal-title":"Blood"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/posicionamento-brasileiro-sobre-o-uso-da-multimodalidade-de-imagens-na-cardio-oncologia-2021\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:06:31Z","timestamp":1747400791000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/posicionamento-brasileiro-sobre-o-uso-da-multimodalidade-de-imagens-na-cardio-oncologia-2021\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":259,"alternative-id":["10.36660\/abc.20200266"],"URL":"https:\/\/doi.org\/10.36660\/abc.20200266","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"value":"0066-782X","type":"print"},{"value":"1678-4170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,27]]}}}